Other acute viral hepatitis

HEPATITIS_ACUTE_OTHER_VIRAL

animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B17 Hospital discharge: ICD-9 — 070[4-9] Cause of death: ICD-10 — B17 Cause of death: ICD-9 — 070[4-9] 2 out of 7 registries used, show all original rules.	498
4. Check minimum number of events None	498
5. Include endpoints None	498
6. Filter based on genotype QC (FinnGen only)	471

Control definitions (FinnGen only)

Control exclude: IBD_VIRAL_HEPATITIS

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: B15-B19
Name in latin: Alia hepatitis viralis acuta

NAME	HEPATITIS_ACUTE_OTHER_VIRAL
CONTROL_EXCLUDE	IBD_VIRAL_HEPATITIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B17
HD_ICD_9	070[4-9]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B17
COD_ICD_9	070[4-9]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other acute viral hepatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	471	243	228
Unadjusted period prevalence (%)	0.10	0.09	0.10
Median age at first event (years)	36.84	35.31	38.46

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
498: Matched controls
4980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B18.2

ICD-10 Finland

Chronic viral hepatitis C

+∞

229.5

202

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

198.6

177

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

11.1

130.4

170

223

0709X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma

+∞

127.7

117

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

34.2

97.0

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

59.2

93.7

B17.8

ICD-10 Finland

Other specified acute viral hepatitis

+∞

87.1

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

+∞

74.9

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.9

68.7

125

230

T36

ICD-10 Finland

Poisoning by systemic antibiotics

9.2

67.2

117

P19

ICPC

Drug abuse

157.1

65.7

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

30.1

65.4

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

335.6

59.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

9.6

55.0

N05BA01

ATC

diazepam; systemic, rectal

5.1

53.5

141

359

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

154.2

53.0

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

154.2

53.0

B17.2

ICD-10 Finland

Acute hepatitis E

551.6

51.4

N05AH04

ATC

quetiapine; oral

4.2

50.6

193

651

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

92.5

45.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.5

44.1

209

N05AH03

ATC

olanzapine; systemic

5.2

39.7

207

N05AA02

ATC

levomepromazine; systemic

7.4

39.6

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

111.5

38.3

Z72.2

ICD-10 Finland

Drug use

144.6

38.3

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

10.6

37.9

N03AE01

ATC

clonazepam; systemic

6.2

37.4

129

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.0

36.4

209

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

187.8

34.2

T74.1

ICD-10 Finland

Physical abuse

8.4

33.3

P15

ICPC

Chronic alcohol abuse

6.8

32.8

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.7

32.8

130

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

344.7

32.2

F10.25

ICD-10 Finland

Alcohol dependence continuous use

10.0

32.2

D72

ICPC

Viral hepatitis

332.8

31.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

30.7

124

419

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.6

30.3

N07BB01

ATC

disulfiram; oral

5.4

30.2

132

N05CD07

ATC

temazepam; oral

4.3

29.4

231

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

6.2

29.3

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

11.8

28.7

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

68.2

28.3

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

297.4

28.0

N05BA04

ATC

oxazepam; oral

2.9

28.0

190

868

N05BA12

ATC

alprazolam; oral

4.0

27.7

266

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

10.9

27.4

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

+∞

27.3

N05AF03

ATC

chlorprothixene; systemic

7.0

27.3

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

79.8

27.1

N03AG01

ATC

valproic acid; systemic, rectal

4.5

26.3

179

F10.09

ICD-10 Finland

Alcohol intoxication UNS

7.5

26.2

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

25.2

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

95.0

24.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

23.4

329

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.1

23.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.1

23.3

F60.9

ICD-10 Finland

Personality disorder, unspecified

9.5

23.2

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

+∞

23.1

IFC01, ,

SPAT

+∞

23.1

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

9.0

23.0

F60.2

ICD-10 Finland

Dissocial personality disorder

87.6

22.9

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

125.8

22.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

22.6

347

R50.9

ICD-10 Finland

Fever, unspecified

3.0

22.3

117

456

Z2446

NOMESCO Finland

Social worker

4.2

22.2

169

P16

ICPC

Acute alcohol abuse

7.3

21.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.5

21.9

236

1322

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

6.6

21.8

N06AX11

ATC

mirtazapine; oral

2.5

21.6

222

1214

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

8.7

21.6

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.4

21.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

21.4

261

1542

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

21.3

105

394

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

29.6

21.2

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

21.0

AA1AD

NOMESCO Finland

CT of head and brain

2.6

20.8

164

789

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

218.8

20.7

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

43.8

20.6

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

60.1

20.1

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

+∞

19.9

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

207.9

19.7

ZY000

NOMESCO Finland

Hospital inpatient

8.4

18.9

F10.24

ICD-10 Finland

Alcohol depence active use

7.4

18.8

N02AX02

ATC

tramadol; systemic, rectal

2.3

18.8

247

1482

A46

ICD-10 Finland

Erysipelas

3.0

18.7

379

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

104.0

18.7

N06AX16

ATC

venlafaxine; oral

2.8

18.6

117

499

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.9

18.6

387

N05AX12

ATC

aripiprazole; systemic

4.3

18.2

127

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

18.1

128

579

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

+∞

17.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

17.7

162

826

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.7

17.7

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

13.8

17.7

J01FF01

ATC

clindamycin; systemic

2.4

17.5

167

868

N06AA12

ATC

doxepin; systemic

4.4

17.2

110

N03AX16

ATC

[U] pregabalin

2.5

17.1

139

671

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

17.0

386

Z3231

NOMESCO Finland

Registered nurse

2.4

16.9

162

841

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.9

16.7

365

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

93.3

16.7

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

93.3

16.7

SPAT1272

SPAT

Drug screening

41.6

16.4

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.2

16.3

119

P18

ICPC

Medication abuse

21.8

16.1

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.4

16.1

N05AD01

ATC

haloperidol; systemic

6.4

16.1

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.0

16.0

N05BA02

ATC

chlordiazepoxide; systemic

6.9

15.9

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

15.9

368

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

62.1

15.9

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

62.1

15.9

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.5

15.8

N03AX09

ATC

lamotrigine; oral

3.6

15.5

162

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

39.4

15.5

A06AD11

ATC

lactulose; oral

3.0

15.5

294

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

4.9

15.4

N05AX08

ATC

risperidone; systemic

3.3

15.3

211

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.1

15.2

J46

ICD-10 Finland

Status asthmaticus

6.5

15.2

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

15.1

130

640

N06AB04

ATC

citalopram; systemic

2.4

15.0

127

620

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

14.9

130

642

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.2

14.8

168

928

C07AA05

ATC

propranolol; systemic

2.3

14.7

142

733

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

14.7

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

82.6

14.6

N05BE01

ATC

buspirone; oral

4.5

14.5

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

154.3

14.5

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

37.3

14.5

S10

ICPC

Boil/carbuncle

3.5

14.5

159

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

43.8

14.2

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

11.4

14.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

14.1

238

Z2221

NOMESCO Finland

Medical doctor

2.2

14.0

159

876

ZY010

NOMESCO Finland

Hospital outpatient

3.5

14.0

158

N06AB05

ATC

paroxetine; oral

3.5

13.7

155

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

+∞

13.6

C03CA01

ATC

furosemide; systemic

2.3

13.6

119

587

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

35.1

13.6

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.4

13.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.5

13.4

147

SPAT1265

SPAT

Breathalyser

14.3

13.4

N05CF02

ATC

zolpidem; oral

2.4

13.3

114

557

N05AN01

ATC

lithium; oral

4.6

13.3

A05AA02

ATC

ursodeoxycholic acid; oral

6.1

13.2

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.8

13.0

115

L03AA04, ,

ATC

51.4

12.9

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

14.6

12.9

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.0

12.8

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

12.8

124

638

X57

ICD-10 Finland

Unspecified privation

5.7

12.7

P29

ICPC

Psychological sympt/compl other

2.8

12.7

270

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.7

12.7

117

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

71.7

12.6

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

33.0

12.6

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

9.7

12.6

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

+∞

12.5

3040A

ICD-9 Finland

Drug dependence, Opioid type dependence

+∞

12.5

N06AB03

ATC

fluoxetine; oral

2.6

12.5

366

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

133.2

12.5

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

133.2

12.5

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.4

12.2

140

A41.9

ICD-10 Finland

Sepsis, unspecified

4.9

12.0

M54.5

ICD-10 Finland

Low back pain

2.0

12.0

216

1394

SPAT1227

SPAT

Substance abuse rehabilitation

15.1

11.9

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

4.0

11.8

N05CF01

ATC

zopiclone; oral

2.0

11.7

167

993

K08.3

ICD-10 Finland

Retained dental root

3.0

11.6

200

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

+∞

11.5

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

+∞

11.5

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

+∞

11.5

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

122.7

11.5

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

122.7

11.5

K76.9

ICD-10 Finland

Liver disease, unspecified

10.0

11.4

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.1

11.3

169

N02BF02

ATC

pregabalin; oral

3.1

11.3

169

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.8

11.3

S06.0

ICD-10 Finland

Concussion

2.5

11.3

325

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

11.2

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

11.1

264

1854

EBA00

NOMESCO Finland

Extraction of tooth

1.9

11.1

209

1360

D10

ICPC

Vomiting

3.0

11.1

176

N06AX12

ATC

bupropion; oral

2.7

11.1

252

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

11.1

229

1537

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

14.3

11.0

S18

ICPC

Laceration/cut

1.9

11.0

239

1629

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

10.9

416

N06AB06

ATC

sertraline; oral

2.4

10.9

403

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

61.3

10.7

6611

FHL

Needle biopsy in the operating room

61.3

10.7

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

10.6

116

Z71.8

ICD-10 Finland

Other specified counselling

1.9

10.6

195

1256

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.8

10.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

10.5

122

L17

ICPC

Foot/toe symptom/complaint

2.0

10.5

162

983

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

10.5

143

831

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

112.3

10.5

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

+∞

10.4

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

+∞

10.4

F40.1

ICD-10 Finland

Social phobias

4.1

10.4

N05AH02

ATC

clozapine; systemic

4.6

10.4

N05AB03

ATC

perphenazine; systemic, rectal

4.0

10.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.2

10.3

134

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

10.2

294

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

10.1

295

A02BC01

ATC

omeprazole; systemic

2.0

10.1

138

800

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

10.1

151

904

R4110

NOMESCO Finland

Physiotherapy

2.0

10.1

146

864

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

15.0

10.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

10.0

119

657

R02

ICPC

Shortness of breath/dyspnoea

2.4

10.0

330

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.7

9.9

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.7

9.9

217

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.4

9.9

M79.6

ICD-10 Finland

Pain in limb

1.8

9.9

237

1649

IHZ04, ,

SPAT

4.7

9.9

N07BA03

ATC

varenicline; oral

3.2

9.9

127

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

10.9

9.9

K72.9

ICD-10 Finland

Hepatic failure, unspecified

20.5

9.8

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

9.8

163

1009

IGV01

NOMESCO Finland

Psychiatric network contact

7.6

9.8

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.0

9.8

155

ZXA05

NOMESCO Finland

Left side

2.1

9.8

113

617

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

5.4

9.7

A28

ICPC

Limited function/disability NOS

2.4

9.7

328

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.2

9.6

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

101.9

9.4

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

30.7

9.4

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

7.1

9.4

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

+∞

9.4

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

9.4

178

1149

S97

ICPC

Chronic ulcer skin

3.2

9.3

126

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

9.3

212

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.0

9.3

148

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.8

9.3

ZXD35

NOMESCO Finland

Usual procedure

4.3

9.3

SPAT1254

SPAT

Administration of medicine

2.3

9.2

341

N03AX12

ATC

[U] gabapentin; oral

2.1

9.2

482

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.3

9.1

P99

ICPC

Psychological disorders other

3.5

9.1

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

9.0

292

WW200

NOMESCO Finland

Immunization

4.5

9.0

SPA47

NOMESCO Finland

Precision impression for denture

4.6

8.9

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

8.9

293

F61.0

ICD-10 Finland

Mixed personality disorders

5.0

8.9

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.2

8.9

119

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.5

8.9

236

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.3

8.8

N06AX05

ATC

trazodone; oral

4.3

8.8

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.7

8.8

ZXY60

NOMESCO Finland

2-person team, nurses

14.4

8.7

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

50.9

8.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.5

8.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

8.6

246

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

8.5

170

1107

A99

ICPC

Disease/condition unspecnature/site

2.4

8.5

266

K75.4

ICD-10 Finland

Autoimmune hepatitis

91.6

8.4

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

91.6

8.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

8.4

377

3100

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

4.8

8.4

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

8.4

107

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.2

8.4

107

2920A

ICD-9 Finland

Drug psychoses, Drug withdrawal syndrome

+∞

8.4

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

+∞

8.4

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

+∞

8.4

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

+∞

8.4

B17.0

ICD-10 Finland

Acute delta-(super)infection in chronic hepatitis B

+∞

8.4

0703A

ICD-9 Finland

Viral hepatitis B without mention of hepatic coma

+∞

8.4

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

11.0

8.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

8.3

Y07

ICD-10 Finland

Other maltreatment

9.7

8.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

8.3

SPAT1307

SPAT

Psychosocial counselling and guidance

2.8

8.3

164

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

4.3

8.3

N06AX21

ATC

duloxetine; oral

2.2

8.2

365

JN4AD

NOMESCO Finland

Body CT examination

2.4

8.2

271

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

4.9

8.2

S76

ICPC

Skin infection other

3.0

8.1

131

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

3.8

8.1

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

4.3

8.1

N02BF01

ATC

gabapentin; oral

2.3

8.0

293

A02BC02

ATC

pantoprazole; systemic

1.8

8.0

331

2636

WX290

NOMESCO Finland

Other blockage of nerve

1.7

8.0

280

2129

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.1

8.0

WX203

NOMESCO Finland

Infraclavicular plexus blockade

4.6

8.0

IEV99

NOMESCO Finland

Other psychiatric network intervention

13.3

7.9

N05AA01

ATC

chlorpromazine; systemic, rectal

7.1

7.8

ZYC01

NOMESCO Finland

Remote contact by phone

2.7

7.8

169

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.1

7.8

IGY02, ,

SPAT

4.6

7.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

7.7

124

ZXE00

NOMESCO Finland

One hour or less

1.7

7.7

189

1301

R44.3

ICD-10 Finland

Hallucinations, unspecified

18.7

7.6

P01AB01

ATC

metronidazole; oral, rectal

1.7

7.6

206

1454

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

7.6

196

Z03

ICPC

Housing/neighbourhood problem

25.4

7.6

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

25.4

7.6

A02BA02

ATC

ranitidine; systemic

2.0

7.6

478

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

7.6

139

879

Z72.0

ICD-10 Finland

Tobacco use

3.8

7.5

Z3226

NOMESCO Finland

Physiotherapist

2.0

7.5

502

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

13.6

7.4

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

3.2

7.4

N05AB01

ATC

dixyrazine; systemic

8.6

7.4

WX730

NOMESCO Finland

Conventional respirator

8.6

7.4

T51.0

ICD-10 Finland

Toxic effect: Ethanol

9.6

7.3

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

7.3

0706X

ICD-9 Finland

Viral hepatitis, Unspecified viral hepatitis with hepatic coma

+∞

7.3

F13.26

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics periodic addiction

+∞

7.3

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

+∞

7.3

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

7.3

WX892

NOMESCO Finland

Monitored bed care

2.6

7.3

175

N30.0

ICD-10 Finland

Acute cystitis

2.0

7.3

455

SPAT1247

SPAT

Outpatient detoxication and monitoring

16.0

7.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.6

7.2

-1, ,

NOMESCO Finland

1.7

7.2

188

1310

SPAT1240

SPAT

Therapeutic discussion

2.1

7.2

342

F13.09

ICD-10 Finland

Intoxication caused by sedative and hypnotic UNS

30.5

7.2

P72

ICPC

Schizophrenia

3.9

7.2

S00.7

ICD-10 Finland

Multiple superficial injuries of head

12.3

7.1

N05AX13

ATC

paliperidone; systemic

12.3

7.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

7.1

105

619

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

7.1

401

SPAT1260

SPAT

Consultation of another employee

2.0

7.1

482

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

10.2

7.1

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.3

7.1

255

K05.31

ICD-10 Finland

Periodontitis pronounced

2.2

7.1

282

J01DB01

ATC

cefalexin; oral

2.0

7.0

419

3639

Z72.1

ICD-10 Finland

Alcohol use

6.0

7.0

N06AB10

ATC

escitalopram; oral

1.8

6.9

126

792

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

6.9

180

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.9

6.9

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

8.4

6.9

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

11.1

6.8

WYA30, ,

SPAT

9.5

6.8

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

9.5

6.8

SPAT1270

SPAT

Narcotic/sobriety test

40.6

6.8

Z3229

NOMESCO Finland

Other healthcare associate professional

2.5

6.8

188

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

6.7

281

R18

ICD-10 Finland

Ascites

6.6

6.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

6.7

164

1120

WX002

NOMESCO Finland

Sedation and analgesia

1.9

6.6

492

D01

ICPC

Abdominal pain/cramps general

2.1

6.6

367

ZXD05

NOMESCO Finland

Urgent procedure

1.7

6.6

150

1003

309

Kela drug reimbursment

Nalmefene and naltrexone

8.9

6.6

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

10.2

6.6

SPAT1283

SPAT

Restricted health certificate

1.8

6.5

109

666

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.6

6.5

160

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.0

6.5

EB1HA, ,

SPAT

4.0

6.5

IBZ14, ,

SPAT

70.7

6.4

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

70.7

6.4

SGA02

NOMESCO Finland

Opening and preparing the root canals

2.0

6.4

422

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

6.4

108

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.8

6.4

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

14.5

6.4

K70.1

ICD-10 Finland

Alcoholic hepatitis

14.5

6.4

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

14.5

6.4

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

4.2

6.4

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

8.3

6.4

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.3

6.4

N06BA04

ATC

methylphenidate; oral

2.7

6.3

132

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

9.4

6.3

A01

ICPC

Pain general/multiple sites

2.2

6.3

275

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

+∞

6.3

T40.1

ICD-10 Finland

Poisoning: Heroin

+∞

6.3

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

+∞

6.3

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

6.3

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

+∞

6.3

O35.4

ICD-10 Finland

Maternal care for (suspected) damage to fetus from alcohol

+∞

6.3

F19.51

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances paranoid

+∞

6.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.0

6.3

N02AA05

ATC

oxycodone; systemic

2.0

6.2

404

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

27.0

6.2

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

27.0

6.2

L12

ICPC

Hand/finger symptom/complaint

1.8

6.2

572

A10AE04

ATC

insulin glargine; parenteral

2.2

6.2

262

W17

ICD-10 Finland

Other fall from one level to another

3.1

6.2

S51.8

ICD-10 Finland

Open wound of other parts of forearm

6.4

6.2

N02BE01

ATC

paracetamol; systemic, rectal

2.0

6.2

440

3926

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

6.2

Z06

ICPC

Unemployment problem

7.8

6.2

P01

ICPC

Feeling anxious/nervous/tense

1.9

6.1

482

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

6.1

178

X84

ICD-10 Finland

Intentional self-harm by unspecified means

12.7

6.1

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.1

6.1

321

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

10.2

6.1

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

8.1e-01

1.8e+00

4.0e+00

1.0e+50

4.4e+00

2.0e+00

1.2e+00

cases:9.50%

controls:4.46%

cases:11.88%

controls:2.15%

cases:13.82%

controls:0.30%

cases:5.40%

controls:0.00%

cases:14.94%

controls:0.22%

cases:14.76%

controls:2.20%

cases:15.79%

controls:5.32%

205

419

4393

408

4499

399

4584

438

4598

393

4582

100

387

4441

211

336

3755

Gastroenterology
10 [38004455]

9.0e-01

1.6e+00

3.0e+00

1.0e+50

3.4e+00

2.9e+00

2.0e+00

cases:7.34%

controls:3.11%

cases:5.83%

controls:1.22%

cases:5.18%

controls:0.28%

cases:17.06%

controls:0.00%

cases:8.66%

controls:0.30%

cases:19.16%

controls:1.28%

cases:18.55%

controls:2.98%

143

429

4455

436

4542

439

4585

384

4598

422

4578

367

4483

118

325

3848

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

6.7e-01

1.6e+00

3.9e+00

1.0e+50

3.9e+00

2.0e+00

1.3e+00

cases:12.53%

controls:6.85%

cases:13.39%

controls:3.13%

cases:20.30%

controls:0.50%

cases:12.74%

controls:0.00%

cases:21.65%

controls:0.57%

cases:20.04%

controls:3.15%

cases:19.80%

controls:6.35%

315

405

4283

144

401

4454

369

4575

404

4598

100

362

4566

143

363

4398

252

320

3714

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

8.0e-01

1.4e+00

3.9e+00

1.0e+50

4.1e+00

1.9e+00

1.2e+00

cases:10.37%

controls:4.96%

cases:9.50%

controls:2.52%

cases:11.88%

controls:0.28%

cases:3.46%

controls:0.00%

cases:14.94%

controls:0.28%

cases:14.32%

controls:2.55%

cases:16.29%

controls:5.37%

228

415

4370

116

419

4482

408

4585

447

4598

393

4579

116

389

4425

213

334

3753

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

7.5e-01

1.8e+00

4.2e+00

1.0e+50

3.7e+00

1.4e+00

1.2e+00

cases:7.56%

controls:3.72%

cases:8.42%

controls:1.44%

cases:9.50%

controls:0.15%

cases:6.05%

controls:0.00%

cases:8.01%

controls:0.22%

cases:6.39%

controls:1.59%

cases:10.78%

controls:3.56%

171

428

4427

424

4532

419

4591

435

4598

425

4582

425

4469

141

356

3825

Prothrombin time (PT) actual/Normal
5894-1 [3033658]

5.7e-01

1.4e+00

4.1e+00

—

4.3e+00

1.9e+00

1.4e+00

cases:5.83%

controls:3.37%

cases:5.83%

controls:1.52%

cases:7.34%

controls:0.13%

—

cases:9.74%

controls:0.15%

cases:8.37%

controls:1.30%

cases:9.77%

controls:2.67%

155

436

4443

436

4528

429

4592

—

417

4585

416

4482

106

360

3860

diazepam; oral, parenteral, rectal
N05BA01 [21604566]

1.9e+00

2.0e+00

2.3e+00

—

2.3e+00

2.1e+00

2.2e+00

cases:10.15%

controls:1.70%

cases:6.05%

controls:0.85%

cases:2.59%

controls:0.26%

—

cases:2.38%

controls:0.24%

cases:6.83%

controls:0.90%

cases:15.54%

controls:1.97%

416

4520

435

4559

451

4586

—

451

4581

423

4500

337

3888

HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]

7.0e-01

1.8e+00

2.9e+00

—

3.9e+00

1.6e+00

1.2e+00

cases:7.78%

controls:4.02%

cases:8.64%

controls:1.57%

cases:4.75%

controls:0.28%

—

cases:4.98%

controls:0.11%

cases:6.61%

controls:1.45%

cases:13.03%

controls:4.29%

185

427

4413

423

4526

441

4585

—

439

4587

424

4475

170

347

3796

Bacteria identified in Blood by Culture
600-7 [3023368]

9.8e-01

1.3e+00

3.2e+00

1.0e+50

3.1e+00

1.6e+00

1.4e+00

cases:6.48%

controls:2.52%

cases:3.46%

controls:0.96%

cases:3.46%

controls:0.15%

cases:3.02%

controls:0.00%

cases:3.90%

controls:0.17%

cases:5.07%

controls:1.06%

cases:8.27%

controls:2.27%

116

433

4482

447

4554

447

4591

449

4598

444

4584

431

4493

366

3876

Psychiatry
26 [38004469]

1.7e+00

1.9e+00

—

2.0e+00

2.1e+00

1.8e+00

cases:22.46%

controls:5.09%

cases:16.85%

controls:2.94%

cases:7.13%

controls:1.11%

—

cases:7.36%

controls:1.11%

cases:18.94%

controls:2.84%

cases:26.57%

controls:5.77%

104

234

359

4364

135

385

4463

430

4547

—

428

4541

129

368

4412

106

229

293

3737

Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]

3.5e-01

7.2e-01

2.4e+00

5.0e+00

2.3e+00

7.4e-01

3.5e-01

cases:25.05%

controls:19.03%

cases:24.62%

controls:13.75%

cases:20.52%

controls:2.24%

cases:14.47%

controls:0.11%

cases:19.05%

controls:2.29%

cases:25.11%

controls:13.79%

cases:29.07%

controls:22.34%

116

875

347

3723

114

632

349

3966

103

368

4495

396

4593

105

374

4487

114

626

340

3915

116

886

283

3080

Methadone [Presence] in Urine by Screen method
19550-3 [3028707]

2.6e+00

3.1e+00

—

2.9e+00

2.5e+00

cases:4.10%

controls:0.33%

cases:3.67%

controls:0.17%

—

cases:2.86%

controls:0.15%

cases:5.51%

controls:0.45%

444

4583

446

4590

—

441

4534

377

3948

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

3.5e-01

7.3e-01

2.5e+00

4.9e+00

2.3e+00

7.7e-01

3.6e-01

cases:24.84%

controls:18.88%

cases:24.62%

controls:13.66%

cases:20.52%

controls:2.17%

cases:14.69%

controls:0.13%

cases:19.05%

controls:2.29%

cases:25.33%

controls:13.57%

cases:29.07%

controls:22.21%

115

868

348

3730

114

628

349

3970

100

368

4498

395

4592

105

374

4487

115

616

339

3925

116

881

283

3085

Internal Medicine
11 [38004456]

9.6e-01

1.1e+00

2.7e+00

—

3.0e+00

1.8e+00

1.3e+00

cases:28.94%

controls:13.44%

cases:15.77%

controls:5.63%

cases:11.02%

controls:0.80%

—

cases:16.23%

controls:1.00%

cases:24.89%

controls:5.02%

cases:35.84%

controls:13.59%

134

618

329

3980

259

390

4339

412

4561

—

387

4546

113

228

341

4313

143

539

256

3427

Emergency Room and Inpatient Visit
ERIP [262]

6.9e-01

1.2e+00

3.6e+00

1.0e+50

2.8e+00

1.5e+00

1.0e+00

cases:6.70%

controls:3.48%

cases:6.05%

controls:1.87%

cases:4.54%

controls:0.13%

cases:7.99%

controls:0.00%

cases:3.25%

controls:0.20%

cases:7.27%

controls:1.70%

cases:10.78%

controls:4.11%

160

432

4438

435

4512

442

4592

426

4598

447

4583

421

4464

163

356

3803

Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]

2.1e-01

5.5e-01

2.3e+00

4.7e+00

2.1e+00

7.5e-01

4.2e-01

cases:18.14%

controls:15.20%

cases:18.79%

controls:11.81%

cases:18.79%

controls:2.20%

cases:10.80%

controls:0.11%

cases:14.94%

controls:2.20%

cases:22.69%

controls:12.20%

cases:25.81%

controls:18.63%

699

379

3899

543

376

4055

101

376

4497

413

4593

101

393

4491

103

554

351

3987

103

739

296

3227

Office Visit
OMOP4822458 [581477]

8.9e-01

1.5e+00

2.9e+00

—

3.1e+00

1.4e+00

9.2e-01

cases:11.23%

controls:4.96%

cases:5.62%

controls:1.30%

cases:1.94%

controls:0.11%

—

cases:2.81%

controls:0.13%

cases:5.07%

controls:1.28%

cases:10.03%

controls:4.24%

228

411

4370

437

4538

454

4593

—

449

4586

431

4483

168

359

3798

INR in Blood by Coagulation assay
34714-6 [3032080]

4.6e-01

1.3e+00

3.2e+00

—

3.2e+00

1.8e+00

1.2e+00

cases:8.42%

controls:5.48%

cases:9.07%

controls:2.57%

cases:12.53%

controls:0.61%

—

cases:14.29%

controls:0.68%

cases:13.00%

controls:2.38%

cases:12.53%

controls:4.34%

252

424

4346

118

421

4480

405

4570

—

396

4561

108

395

4433

172

349

3794

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

2.6e-01

5.8e-01

2.3e+00

4.9e+00

2.1e+00

7.4e-01

2.5e-01

cases:26.13%

controls:21.42%

cases:26.13%

controls:16.53%

cases:23.97%

controls:3.11%

cases:14.90%

controls:0.13%

cases:20.35%

controls:2.92%

cases:29.74%

controls:16.87%

cases:30.33%

controls:25.29%

121

985

342

3613

121

760

342

3838

111

143

352

4455

394

4592

134

368

4458

135

766

319

3775

121

1003

278

2963

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

2.7e-01

7.0e-01

2.2e+00

4.8e+00

2.1e+00

7.9e-01

3.6e-01

cases:20.30%

controls:16.27%

cases:21.60%

controls:12.07%

cases:19.22%

controls:2.48%

cases:11.45%

controls:0.11%

cases:17.53%

controls:2.53%

cases:23.13%

controls:12.02%

cases:24.81%

controls:18.78%

748

369

3850

100

555

363

4043

114

374

4484

410

4593

116

381

4476

105

546

349

3995

745

300

3221

Treatment of a patient needing special arrangements
WYA30 [2001310874]

2.0e+00

2.4e+00

—

3.1e+00

3.0e+00

cases:4.10%

controls:0.59%

cases:2.16%

controls:0.20%

—

cases:4.41%

controls:0.20%

cases:8.52%

controls:0.45%

444

4571

453

4589

—

434

4532

365

3948

clonazepam; oral, parenteral
N03AE01 [21604415]

2.6e+00

2.4e+00

—

2.6e+00

2.8e+00

cases:4.54%

controls:0.35%

cases:2.38%

controls:0.22%

—

cases:2.64%

controls:0.20%

cases:6.27%

controls:0.40%

442

4582

452

4588

—

442

4532

374

3950

General Practice
1 [38004446]

9.9e-01

1.4e+00

3.0e+00

—

2.2e+00

1.5e+00

1.3e+00

cases:16.41%

controls:6.83%

cases:9.07%

controls:2.35%

cases:4.32%

controls:0.22%

—

cases:2.81%

controls:0.30%

cases:9.91%

controls:2.42%

cases:20.05%

controls:6.68%

314

387

4284

108

421

4490

443

4588

—

449

4578

110

409

4431

265

319

3701

Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]

2.2e+00

3.1e+00

1.0e+50

—

2.5e+00

2.4e+00

cases:4.32%

controls:0.48%

cases:4.32%

controls:0.20%

cases:1.51%

controls:0.00%

—

cases:3.74%

controls:0.31%

cases:8.52%

controls:0.86%

443

4576

443

4589

456

4598

—

437

4527

365

3932

quetiapine; oral
N05AH04 [21604544]

1.6e+00

1.8e+00

—

1.6e+00

1.8e+00

1.7e+00

cases:12.10%

controls:2.74%

cases:10.15%

controls:1.89%

cases:3.24%

controls:0.57%

—

cases:3.03%

controls:0.63%

cases:10.57%

controls:1.92%

cases:13.03%

controls:2.77%

126

407

4472

416

4511

448

4572

—

448

4563

406

4454

110

347

3856

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

4.1e-01

1.0e+00

3.4e+00

1.0e+50

3.1e+00

1.6e+00

9.1e-01

cases:17.06%

controls:12.03%

cases:16.85%

controls:6.66%

cases:23.33%

controls:0.98%

cases:14.04%

controls:0.00%

cases:22.94%

controls:1.26%

cases:26.65%

controls:6.83%

cases:25.56%

controls:12.15%

553

384

4045

306

385

4292

108

355

4553

398

4598

106

356

4534

121

310

333

4231

102

482

297

3484

MCH [Entitic mass]
28539-5 [3035941]

1.4e-01

4.4e-01

2.1e+00

4.8e+00

2.1e+00

5.7e-01

1.1e-01

cases:27.43%

controls:24.77%

cases:27.65%

controls:19.68%

cases:25.49%

controls:3.98%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.61%

cases:30.84%

controls:20.06%

cases:31.33%

controls:29.07%

127

1139

336

3459

128

905

335

3693

118

183

345

4415

389

4591

110

166

352

4426

140

911

314

3630

125

1153

274

2813

Platelets [#/volume] in Blood
26515-7 [3007461]

1.4e-01

4.5e-01

2.1e+00

4.8e+00

2.1e+00

5.7e-01

1.1e-01

cases:27.43%

controls:24.64%

cases:27.65%

controls:19.57%

cases:25.70%

controls:4.00%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.66%

cases:30.84%

controls:20.11%

cases:31.33%

controls:29.05%

127

1133

336

3465

128

900

335

3698

119

184

344

4414

389

4591

110

168

352

4424

140

913

314

3628

125

1152

274

2814

Emergency Room Visit
ER [9203]

7.9e-01

1.4e+00

3.1e+00

—

2.3e+00

1.5e+00

9.1e-01

cases:34.77%

controls:19.55%

cases:21.38%

controls:6.05%

cases:14.25%

controls:0.74%

—

cases:7.36%

controls:0.81%

cases:21.37%

controls:5.51%

cases:38.10%

controls:19.82%

161

899

302

3699

278

364

4320

397

4564

—

428

4555

250

357

4291

152

786

247

3180

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

1.4e-01

4.4e-01

2.1e+00

4.8e+00

2.1e+00

5.6e-01

1.1e-01

cases:27.43%

controls:24.79%

cases:27.65%

controls:19.68%

cases:25.49%

controls:3.98%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.61%

cases:30.62%

controls:20.06%

cases:31.33%

controls:29.07%

127

1140

336

3458

128

905

335

3693

118

183

345

4415

389

4591

110

166

352

4426

139

911

315

3630

125

1153

274

2813

Hemoglobin [Mass/volume] in Blood
718-7 [3000963]

1.3e-01

4.4e-01

2.1e+00

4.8e+00

2.1e+00

5.8e-01

1.0e-01

cases:27.43%

controls:24.86%

cases:27.65%

controls:19.68%

cases:25.49%

controls:4.00%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.68%

cases:31.06%

controls:20.11%

cases:31.33%

controls:29.20%

127

1143

336

3455

128

905

335

3693

118

184

345

4414

389

4591

110

169

352

4423

141

913

313

3628

125

1158

274

2808

Erythrocytes [#/volume] in Blood
26453-1 [3026361]

1.4e-01

4.4e-01

2.1e+00

4.8e+00

2.1e+00

5.7e-01

1.1e-01

cases:27.43%

controls:24.79%

cases:27.65%

controls:19.68%

cases:25.49%

controls:4.00%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.66%

cases:30.84%

controls:20.11%

cases:31.33%

controls:29.10%

127

1140

336

3458

128

905

335

3693

118

184

345

4414

389

4591

110

168

352

4424

140

913

314

3628

125

1154

274

2812

Leukocytes [#/volume] in Blood
26464-8 [3010813]

1.3e-01

4.4e-01

2.1e+00

4.8e+00

2.1e+00

5.7e-01

1.1e-01

cases:27.43%

controls:24.86%

cases:27.65%

controls:19.73%

cases:25.49%

controls:4.02%

cases:15.98%

controls:0.15%

cases:23.81%

controls:3.68%

cases:30.84%

controls:20.06%

cases:31.33%

controls:29.10%

127

1143

336

3455

128

907

335

3691

118

185

345

4413

389

4591

110

169

352

4423

140

911

314

3630

125

1154

274

2812

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

4.3e-01

1.4e+00

3.3e+00

1.0e+50

3.3e+00

1.4e+00

5.9e-01

cases:15.98%

controls:11.05%

cases:15.98%

controls:4.39%

cases:14.90%

controls:0.65%

cases:7.13%

controls:0.00%

cases:15.58%

controls:0.68%

cases:17.84%

controls:5.20%

cases:21.55%

controls:13.26%

508

389

4090

202

389

4396

394

4568

430

4598

390

4561

236

373

4305

526

313

3440

Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]

1.4e-01

4.5e-01

2.1e+00

4.7e+00

2.1e+00

5.7e-01

1.1e-01

cases:27.43%

controls:24.82%

cases:27.65%

controls:19.66%

cases:25.49%

controls:4.00%

cases:15.98%

controls:0.17%

cases:23.81%

controls:3.66%

cases:30.84%

controls:20.08%

cases:31.33%

controls:29.07%

127

1141

336

3457

128

904

335

3694

118

184

345

4414

389

4590

110

168

352

4424

140

912

314

3629

125

1153

274

2813

temazepam; oral
N05CD07 [21604642]

1.9e+00

1.8e+00

—

2.3e+00

2.1e+00

1.8e+00

cases:8.64%

controls:1.41%

cases:4.32%

controls:0.72%

cases:1.08%

controls:0.17%

—

cases:1.95%

controls:0.20%

cases:5.51%

controls:0.73%

cases:9.77%

controls:1.74%

423

4533

443

4565

458

4590

—

453

4583

429

4508

360

3897

Outpatient Visit
OP [9202]

4.0e-01

5.0e-01

1.2e+00

4.6e+00

1.6e+00

8.7e-01

6.4e-01

cases:60.04%

controls:50.07%

cases:42.33%

controls:30.73%

cases:17.06%

controls:5.74%

cases:23.76%

controls:0.30%

cases:23.16%

controls:5.81%

cases:50.00%

controls:29.49%

cases:66.92%

controls:51.64%

278

2302

185

2296

196

1413

267

3185

264

384

4334

110

353

4584

107

267

355

4325

227

1339

227

3202

267

2048

132

1918

Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]

2.4e+00

2.9e+00

—

2.5e+00

2.0e+00

cases:5.18%

controls:0.50%

cases:4.10%

controls:0.24%

—

cases:3.74%

controls:0.31%

cases:6.52%

controls:0.91%

439

4575

444

4587

—

437

4527

373

3930

Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]

1.1e+00

2.3e+00

—

1.0e+50

2.7e+00

2.0e+00

1.5e+00

cases:6.05%

controls:2.09%

cases:5.40%

controls:0.54%

—

cases:1.08%

controls:0.00%

cases:1.95%

controls:0.13%

cases:4.19%

controls:0.62%

cases:9.27%

controls:2.22%

435

4502

438

4573

—

458

4598

453

4586

435

4513

362

3878

Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]

8.1e-01

2.1e+00

4.0e+00

—

1.5e+00

1.2e+00

cases:6.48%

controls:2.98%

cases:8.42%

controls:1.13%

cases:9.50%

controls:0.20%

—

cases:4.41%

controls:1.01%

cases:9.77%

controls:3.10%

137

433

4461

424

4546

419

4589

—

434

4495

123

360

3843

Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]

2.1e+00

2.8e+00

—

1.0e+50

—

2.2e+00

2.4e+00

cases:5.62%

controls:0.72%

cases:3.02%

controls:0.20%

—

cases:1.30%

controls:0.00%

—

cases:1.76%

controls:0.20%

cases:5.76%

controls:0.55%

437

4565

449

4589

—

457

4598

—

446

4532

376

3944

Upper gastrointestinal surgery
106 [44777669]

6.7e-01

1.2e+00

2.5e+00

—

2.7e+00

1.4e+00

9.9e-01

cases:8.21%

controls:4.39%

cases:5.62%

controls:1.70%

cases:2.38%

controls:0.20%

—

cases:3.03%

controls:0.22%

cases:6.83%

controls:1.81%

cases:10.03%

controls:3.96%

202

425

4396

437

4520

452

4589

—

448

4582

423

4459

157

359

3809

pregabalin; oral
N02BF02 [955152]

1.2e+00

1.6e+00

2.1e+00

—

2.0e+00

1.1e+00

1.4e+00

cases:6.70%

controls:2.11%

cases:4.54%

controls:0.98%

cases:2.38%

controls:0.30%

—

cases:2.38%

controls:0.33%

cases:3.74%

controls:1.26%

cases:6.02%

controls:1.56%

432

4501

442

4553

452

4584

—

451

4577

437

4484

375

3904

Cocaine [Presence] in Urine
3397-7 [3016879]

2.1e+00

2.8e+00

—

2.5e+00

2.0e+00

cases:4.97%

controls:0.61%

cases:4.32%

controls:0.28%

—

cases:3.74%

controls:0.33%

cases:7.02%

controls:1.06%

440

4570

443

4585

—

437

4526

371

3924

Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]

2.2e+00

2.5e+00

—

2.5e+00

1.8e+00

cases:2.81%

controls:0.30%

cases:2.16%

controls:0.17%

—

cases:2.20%

controls:0.18%

cases:4.26%

controls:0.76%

450

4584

453

4590

—

444

4533

382

3936

Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]

6.4e-01

1.0e+00

2.9e+00

—

2.4e+00

1.1e+00

1.0e+00

cases:14.25%

controls:8.09%

cases:9.07%

controls:3.39%

cases:6.26%

controls:0.37%

—

cases:4.55%

controls:0.41%

cases:9.47%

controls:3.44%

cases:18.05%

controls:7.51%

372

397

4226

156

421

4442

434

4581

—

441

4573

156

411

4385

298

327

3668

pH of Serum or Plasma
2753-2 [3018418]

9.1e-01

1.3e+00

2.1e+00

—

2.2e+00

1.5e+00

1.1e+00

cases:6.91%

controls:2.91%

cases:5.62%

controls:1.65%

cases:2.16%

controls:0.28%

—

cases:1.95%

controls:0.22%

cases:6.17%

controls:1.48%

cases:8.77%

controls:3.08%

134

431

4464

437

4522

453

4585

—

453

4582

426

4474

122

364

3844

gabapentin; oral
N02BF01 [955005]

1.1e+00

1.2e+00

1.9e+00

—

2.1e+00

1.2e+00

1.5e+00

cases:4.10%

controls:1.35%

cases:2.81%

controls:0.89%

cases:1.51%

controls:0.24%

—

cases:1.95%

controls:0.24%

cases:3.52%

controls:1.10%

cases:6.27%

controls:1.44%

444

4536

450

4557

456

4587

—

453

4581

438

4491

374

3909

Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]

7.7e-01

1.2e+00

2.4e+00

—

2.2e+00

1.3e+00

1.0e+00

cases:10.15%

controls:4.96%

cases:7.99%

controls:2.48%

cases:4.32%

controls:0.39%

—

cases:3.68%

controls:0.41%

cases:8.37%

controls:2.44%

cases:12.03%

controls:4.77%

228

416

4370

114

426

4484

443

4580

—

445

4573

111

416

4430

189

351

3777

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

1.4e+00

1.8e+00

2.6e+00

—

2.0e+00

1.1e+00

cases:4.75%

controls:1.20%

cases:4.32%

controls:0.74%

cases:1.73%

controls:0.13%

—

cases:4.63%

controls:0.68%

cases:4.76%

controls:1.56%

441

4543

443

4564

455

4592

—

433

4510

380

3904

Benzodiazepines [Presence] in Urine
3390-2 [3000764]

2.0e+00

2.7e+00

—

2.3e+00

1.9e+00

cases:5.18%

controls:0.72%

cases:4.32%

controls:0.30%

—

cases:3.74%

controls:0.40%

cases:7.02%

controls:1.11%

439

4565

443

4584

—

437

4523

371

3922

Cannabinoids [Presence] in Urine
3427-2 [3028300]

2.0e+00

2.7e+00

—

2.3e+00

1.9e+00

cases:5.18%

controls:0.72%

cases:4.32%

controls:0.30%

—

cases:3.74%

controls:0.40%

cases:7.02%

controls:1.13%

439

4565

443

4584

—

437

4523

371

3921

Inpatient Hospital
21 [8717]

7.3e-01

9.3e-01

2.6e+00

1.0e+50

2.3e+00

1.3e+00

9.5e-01

cases:34.34%

controls:20.07%

cases:15.98%

controls:6.98%

cases:8.86%

controls:0.70%

cases:27.86%

controls:0.00%

cases:8.23%

controls:0.91%

cases:21.81%

controls:6.76%

cases:42.36%

controls:22.11%

159

923

304

3675

321

389

4277

422

4566

129

334

4598

424

4550

307

355

4234

169

877

230

3089

Creatinine [Moles/volume] in Urine
14683-7 [3009508]

1.1e+00

1.3e+00

2.9e+00

—

2.9e+00

6.7e-01

6.4e-01

cases:11.02%

controls:4.00%

cases:8.42%

controls:2.57%

cases:2.81%

controls:0.15%

—

cases:2.81%

controls:0.15%

cases:5.95%

controls:3.15%

cases:10.53%

controls:5.85%

184

412

4414

118

424

4480

450

4591

—

449

4585

143

427

4398

232

357

3734

Opiates [Presence] in Urine
3879-4 [3027008]

2.0e+00

2.7e+00

—

2.3e+00

1.9e+00

cases:5.18%

controls:0.72%

cases:4.32%

controls:0.30%

—

cases:3.74%

controls:0.40%

cases:7.02%

controls:1.16%

439

4565

443

4584

—

437

4523

371

3920

Infectious Disease
44 [38004484]

1.3e+00

2.2e+00

—

1.0e+50

—

2.9e+00

2.3e+00

cases:4.10%

controls:1.11%

cases:2.59%

controls:0.28%

—

cases:4.10%

controls:0.00%

—

cases:5.95%

controls:0.35%

cases:9.02%

controls:1.01%

444

4547

451

4585

—

444

4598

—

427

4525

363

3926

Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]

9.7e-01

2.5e+00

3.8e+00

1.0e+50

—

1.1e+00

1.5e+00

cases:5.83%

controls:2.28%

cases:8.64%

controls:0.80%

cases:6.91%

controls:0.17%

cases:4.10%

controls:0.00%

—

cases:1.98%

controls:0.66%

cases:8.77%

controls:2.02%

105

436

4493

423

4561

431

4590

444

4598

—

445

4511

364

3886

tramadol; oral, parenteral, rectal
N02AX02 [21604298]

1.2e+00

1.3e+00

1.7e+00

—

2.3e+00

1.1e+00

cases:10.37%

controls:3.48%

cases:4.75%

controls:1.35%

cases:2.16%

controls:0.39%

—

cases:2.81%

controls:0.28%

cases:4.63%

controls:1.61%

cases:10.78%

controls:3.91%

160

415

4438

441

4536

453

4580

—

449

4579

433

4468

155

356

3811

Amphetamines [Presence] in Urine
3349-8 [3027944]

2.0e+00

2.6e+00

—

2.3e+00

1.8e+00

cases:4.97%

controls:0.72%

cases:3.89%

controls:0.30%

—

cases:3.52%

controls:0.37%

cases:6.77%

controls:1.16%

440

4565

445

4584

—

438

4524

372

3920

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

6.6e-01

1.1e+00

2.3e+00

—

2.4e+00

1.3e+00

9.3e-01

cases:10.15%

controls:5.52%

cases:8.42%

controls:3.00%

cases:4.32%

controls:0.46%

—

cases:3.90%

controls:0.37%

cases:9.25%

controls:2.82%

cases:13.53%

controls:5.82%

254

416

4344

138

424

4460

443

4577

—

444

4575

128

412

4413

231

345

3735

Inpatient Visit
IP [9201]

4.5e-01

8.6e-01

2.1e+00

—

2.6e+00

1.5e+00

1.1e+00

cases:22.68%

controls:15.72%

cases:9.07%

controls:4.05%

cases:3.02%

controls:0.39%

—

cases:4.11%

controls:0.30%

cases:12.11%

controls:3.11%

cases:14.79%

controls:5.42%

105

723

358

3875

186

421

4412

449

4580

—

443

4578

141

399

4400

215

340

3751

Unspecified nonorganic psychosis
F29 [45533099]

1.7e+00

1.9e+00

2.1e+00

1.0e+50

—

2.2e+00

2.7e+00

cases:3.89%

controls:0.72%

cases:1.73%

controls:0.26%

cases:1.08%

controls:0.13%

cases:1.51%

controls:0.00%

—

cases:2.42%

controls:0.29%

cases:5.51%

controls:0.40%

445

4565

455

4586

458

4592

456

4598

—

443

4528

377

3950

Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]

5.5e-01

1.1e+00

2.9e+00

—

2.5e+00

1.1e+00

8.5e-01

cases:7.56%

controls:4.50%

cases:5.40%

controls:1.94%

cases:3.89%

controls:0.22%

—

cases:2.81%

controls:0.24%

cases:5.95%

controls:2.16%

cases:8.77%

controls:3.93%

207

428

4391

438

4509

445

4588

—

449

4581

427

4443

156

364

3810

Poisoning by systemic antibiotics
T36 [45756588]

2.6e+00

—

3.1e+00

2.6e+00

cases:4.97%

controls:0.37%

—

cases:2.86%

controls:0.13%

cases:4.51%

controls:0.35%

440

4581

—

441

4535

381

3952

Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]

1.3e+00

2.1e+00

—

1.0e+50

—

3.1e+00

1.8e+00

cases:2.81%

controls:0.80%

cases:3.67%

controls:0.48%

—

cases:2.38%

controls:0.00%

—

cases:5.29%

controls:0.24%

cases:5.01%

controls:0.86%

450

4561

446

4576

—

452

4598

—

430

4530

379

3932

Emergency Medicine
93 [38004510]

5.9e-01

1.0e+00

2.9e+00

1.0e+50

1.9e+00

1.1e+00

6.6e-01

cases:15.55%

controls:9.29%

cases:12.31%

controls:4.87%

cases:9.29%

controls:0.57%

cases:8.64%

controls:0.00%

cases:4.76%

controls:0.74%

cases:12.33%

controls:4.56%

cases:19.30%

controls:10.97%

427

391

4171

224

406

4374

420

4572

423

4598

440

4558

207

398

4334

435

322

3531

Outpatient Hospital
22 [8756]

8.0e-01

7.0e-01

2.2e+00

—

2.0e+00

1.5e+00

8.9e-01

cases:23.33%

controls:11.98%

cases:7.56%

controls:3.91%

cases:3.67%

controls:0.41%

—

cases:3.46%

controls:0.48%

cases:13.22%

controls:3.35%

cases:29.57%

controls:14.67%

108

551

355

4047

180

428

4418

446

4579

—

446

4570

152

394

4389

118

582

281

3384

Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]

2.7e+00

2.1e+00

—

2.2e+00

3.2e+00

cases:3.02%

controls:0.22%

cases:1.08%

controls:0.13%

—

cases:1.32%

controls:0.15%

cases:3.76%

controls:0.15%

449

4588

458

4592

—

448

4534

384

3960

oxazepam; oral
N05BA04 [21604569]

1.5e+00

1.3e+00

1.1e+00

—

2.1e+00

1.6e+00

1.4e+00

cases:11.66%

controls:2.78%

cases:6.91%

controls:1.96%

cases:1.51%

controls:0.50%

—

cases:3.68%

controls:0.46%

cases:7.05%

controls:1.54%

cases:12.28%

controls:3.40%

128

409

4470

431

4508

456

4575

—

445

4571

422

4471

135

350

3831

Laboratory Visit
OMOP4822461 [32036]

9.6e-02

2.2e-01

1.7e+00

4.1e+00

1.6e+00

3.7e-01

2.0e-02

cases:30.67%

controls:28.66%

cases:30.45%

controls:26.05%

cases:29.37%

controls:7.26%

cases:19.01%

controls:0.37%

cases:26.84%

controls:7.01%

cases:34.80%

controls:27.00%

cases:33.33%

controls:32.88%

142

1318

321

3280

141

1198

322

3400

136

334

327

4264

375

4581

124

322

338

4270

158

1226

296

3315

133

1304

266

2662

Normoblasts [#/volume] in Blood
715-3 [3021589]

4.6e-01

8.4e-01

2.3e+00

1.0e+50

2.5e+00

1.1e+00

9.2e-01

cases:9.29%

controls:6.07%

cases:10.15%

controls:4.63%

cases:9.50%

controls:1.04%

cases:3.67%

controls:0.00%

cases:9.52%

controls:0.87%

cases:12.56%

controls:4.54%

cases:15.29%

controls:6.71%

279

420

4319

213

416

4385

419

4550

446

4598

418

4552

206

397

4335

266

338

3700

Other and unspecified abdominal pain
R10.4 [45568113]

7.5e-01

1.8e+00

3.0e+00

—

2.1e+00

1.2e+00

8.2e-01

cases:7.56%

controls:3.72%

cases:4.75%

controls:0.80%

cases:3.02%

controls:0.15%

—

cases:1.08%

controls:0.13%

cases:3.74%

controls:1.17%

cases:8.77%

controls:4.06%

171

428

4427

441

4561

449

4591

—

457

4586

437

4488

161

364

3805

Basophils [#/volume] in Blood
26444-0 [3006315]

5.0e-01

8.1e-01

2.0e+00

1.0e+50

2.7e+00

1.2e+00

8.1e-01

cases:11.88%

controls:7.59%

cases:8.64%

controls:4.02%

cases:5.40%

controls:0.74%

cases:1.08%

controls:0.00%

cases:9.31%

controls:0.70%

cases:11.45%

controls:3.68%

cases:15.79%

controls:7.67%

349

408

4249

185

423

4413

438

4564

458

4598

419

4560

167

402

4374

304

336

3662

Eosinophils [#/volume] in Blood
26449-9 [3013115]

5.0e-01

8.0e-01

2.0e+00

1.0e+50

2.7e+00

1.2e+00

7.9e-01

cases:12.31%

controls:7.85%

cases:8.86%

controls:4.18%

cases:5.62%

controls:0.78%

cases:1.51%

controls:0.00%

cases:9.52%

controls:0.70%

cases:11.89%

controls:3.74%

cases:16.04%

controls:7.97%

361

406

4237

192

422

4406

437

4562

456

4598

418

4560

170

400

4371

316

335

3650

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

2.3e-01

8.2e-01

2.1e+00

—

2.4e+00

1.3e+00

9.9e-01

cases:10.80%

controls:8.81%

cases:9.94%

controls:4.63%

cases:7.34%

controls:1.00%

—

cases:10.17%

controls:1.00%

cases:13.88%

controls:4.38%

cases:19.80%

controls:8.40%

405

413

4193

213

417

4385

429

4552

—

415

4546

199

391

4342

333

320

3633

Bacteria [Presence] in Urine
87829-8 [36304419]

6.6e-01

7.3e-01

3.2e+00

—

2.4e+00

9.5e-01

9.1e-01

cases:6.48%

controls:3.46%

cases:3.24%

controls:1.59%

cases:3.24%

controls:0.13%

—

cases:2.16%

controls:0.20%

cases:3.74%

controls:1.48%

cases:7.02%

controls:2.95%

159

433

4439

448

4525

448

4592

—

452

4583

437

4474

117

371

3849

Specific gravity of Urine by Refractometry
5810-7 [3019150]

6.3e-01

1.3e+00

2.3e+00

—

2.0e+00

1.2e+00

7.6e-01

cases:6.05%

controls:3.31%

cases:4.32%

controls:1.26%

cases:2.81%

controls:0.28%

—

cases:1.52%

controls:0.22%

cases:4.63%

controls:1.41%

cases:6.77%

controls:3.28%

152

435

4446

443

4540

450

4585

—

455

4582

433

4477

130

372

3836

Leukocytes [#/volume] in Urine
30405-5 [3018095]

5.0e-01

8.3e-01

2.6e+00

—

2.6e+00

8.9e-01

6.5e-01

cases:7.13%

controls:4.44%

cases:5.18%

controls:2.33%

cases:3.89%

controls:0.30%

—

cases:3.03%

controls:0.24%

cases:5.73%

controls:2.44%

cases:8.77%

controls:4.77%

204

430

4394

107

439

4491

445

4584

—

448

4581

111

428

4430

189

364

3777

Lymphocytes [#/volume] in Blood
26474-7 [3019198]

5.0e-01

8.1e-01

2.0e+00

—

2.7e+00

1.2e+00

8.2e-01

cases:12.31%

controls:7.85%

cases:8.64%

controls:4.02%

cases:5.40%

controls:0.78%

—

cases:9.31%

controls:0.70%

cases:11.67%

controls:3.77%

cases:16.54%

controls:8.04%

361

406

4237

185

423

4413

438

4562

—

419

4560

171

401

4370

319

333

3647

Monocytes [#/volume] in Blood
26484-6 [3001604]

5.0e-01

8.2e-01

1.9e+00

1.0e+50

2.7e+00

1.2e+00

8.1e-01

cases:11.88%

controls:7.59%

cases:8.64%

controls:4.00%

cases:4.97%

controls:0.74%

cases:1.08%

controls:0.00%

cases:9.31%

controls:0.70%

cases:11.45%

controls:3.63%

cases:15.79%

controls:7.67%

349

408

4249

184

423

4414

440

4564

458

4598

419

4560

165

402

4376

304

336

3662

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

5.5e-01

8.0e-01

2.9e+00

—

2.6e+00

1.0e+00

7.8e-01

cases:6.70%

controls:3.96%

cases:4.32%

controls:1.98%

cases:3.89%

controls:0.22%

—

cases:2.81%

controls:0.22%

cases:5.29%

controls:1.96%

cases:7.77%

controls:3.71%

182

432

4416

443

4507

445

4588

—

449

4582

430

4452

147

368

3819

Differential panel, method unspecified - Blood
69738-3 [42870588]

6.0e-01

8.0e-01

1.7e+00

1.0e+50

2.8e+00

9.6e-01

1.0e+00

cases:8.42%

controls:4.81%

cases:5.40%

controls:2.50%

cases:2.81%

controls:0.50%

cases:1.08%

controls:0.00%

cases:6.71%

controls:0.44%

cases:6.17%

controls:2.44%

cases:11.28%

controls:4.46%

221

424

4377

115

438

4483

450

4575

458

4598

431

4572

111

426

4430

177

354

3789

Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]

1.2e+00

2.4e+00

—

1.0e+50

—

1.6e+00

2.0e+00

cases:3.46%

controls:1.09%

cases:4.75%

controls:0.43%

—

cases:2.59%

controls:0.00%

—

cases:2.20%

controls:0.44%

cases:8.27%

controls:1.16%

447

4548

441

4578

—

451

4598

—

444

4521

366

3920

Short blood count panel - Blood
55429-5 [40758558]

5.5e-01

8.1e-01

2.2e+00

—

2.6e+00

1.1e+00

1.4e+00

cases:5.83%

controls:3.46%

cases:3.67%

controls:1.67%

cases:2.59%

controls:0.28%

—

cases:3.46%

controls:0.26%

cases:4.85%

controls:1.72%

cases:10.03%

controls:2.80%

159

436

4439

446

4521

451

4585

—

446

4580

432

4463

111

359

3855

Monocytes/Leukocytes in Blood
26485-3 [3019069]

3.9e-01

6.7e-01

1.8e+00

1.0e+50

2.6e+00

1.3e+00

9.2e-01

cases:10.37%

controls:7.26%

cases:7.13%

controls:3.76%

cases:4.10%

controls:0.72%

cases:1.51%

controls:0.00%

cases:8.66%

controls:0.68%

cases:10.79%

controls:3.35%

cases:15.54%

controls:6.86%

334

415

4264

173

430

4425

444

4565

456

4598

422

4561

152

405

4389

272

337

3694

General Surgery
2 [38004447]

7.1e-01

6.9e-01

2.3e+00

1.0e+50

1.7e+00

1.2e+00

7.1e-01

cases:22.89%

controls:12.77%

cases:7.13%

controls:3.70%

cases:4.75%

controls:0.52%

cases:4.32%

controls:0.00%

cases:1.95%

controls:0.37%

cases:10.13%

controls:3.33%

cases:23.81%

controls:13.31%

106

587

357

4011

170

430

4428

441

4574

443

4598

453

4575

151

408

4390

528

304

3438

Basophils/Leukocytes in Blood
30180-4 [3022096]

3.8e-01

7.1e-01

1.7e+00

1.0e+50

2.7e+00

1.3e+00

9.2e-01

cases:10.15%

controls:7.16%

cases:7.34%

controls:3.74%

cases:3.67%

controls:0.72%

cases:1.51%

controls:0.00%

cases:8.87%

controls:0.68%

cases:10.79%

controls:3.33%

cases:15.54%

controls:6.86%

329

416

4269

172

429

4426

446

4565

456

4598

421

4561

151

405

4390

272

337

3694

olanzapine; oral, parenteral
N05AH03 [21604543]

1.9e+00

1.6e+00

—

1.3e+00

1.5e+00

2.2e+00

cases:5.83%

controls:0.89%

cases:3.02%

controls:0.65%

—

cases:1.08%

controls:0.28%

cases:3.08%

controls:0.70%

cases:7.27%

controls:0.86%

436

4557

449

4568

—

457

4579

440

4509

370

3932

Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]

6.4e-01

8.8e-01

2.2e+00

—

2.2e+00

1.0e+00

9.8e-01

cases:6.26%

controls:3.41%

cases:4.10%

controls:1.74%

cases:1.30%

controls:0.15%

—

cases:1.30%

controls:0.15%

cases:4.41%

controls:1.67%

cases:7.77%

controls:3.08%

157

434

4441

444

4518

457

4591

—

456

4585

434

4465

122

368

3844

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

4.3e-01

6.9e-01

1.7e+00

—

2.7e+00

1.2e+00

8.8e-01

cases:11.02%

controls:7.44%

cases:7.34%

controls:3.81%

cases:4.10%

controls:0.76%

—

cases:8.87%

controls:0.68%

cases:10.79%

controls:3.52%

cases:15.79%

controls:7.24%

342

412

4256

175

429

4423

444

4563

—

421

4561

160

405

4381

287

336

3679

Eosinophils/Leukocytes in Blood
26450-7 [3006504]

4.1e-01

6.9e-01

1.7e+00

1.0e+50

2.6e+00

1.2e+00

9.2e-01

cases:10.37%

controls:7.16%

cases:7.13%

controls:3.72%

cases:3.67%

controls:0.72%

cases:1.51%

controls:0.00%

cases:8.66%

controls:0.68%

cases:10.79%

controls:3.37%

cases:15.54%

controls:6.83%

329

415

4269

171

430

4427

446

4565

456

4598

422

4561

153

405

4388

271

337

3695

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

6.5e-01

8.9e-01

3.0e+00

—

2.2e+00

1.0e+00

8.8e-01

cases:6.48%

controls:3.50%

cases:3.89%

controls:1.63%

cases:3.24%

controls:0.17%

—

cases:2.16%

controls:0.24%

cases:4.63%

controls:1.67%

cases:7.02%

controls:3.03%

161

433

4437

445

4523

448

4590

—

452

4581

433

4465

120

371

3846

Ultrasound examination of upper part of abdomen
JN1AE [2001305517]

9.7e-01

2.5e+00

1.0e+50

—

2.6e+00

1.9e+00

cases:1.08%

controls:0.41%

cases:1.30%

controls:0.11%

cases:3.24%

controls:0.00%

cases:5.83%

controls:0.00%

—

cases:1.98%

controls:0.15%

cases:2.51%

controls:0.38%

458

4579

457

4593

448

4598

436

4598

—

445

4534

389

3951

C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]

2.5e-01

7.1e-01

2.6e+00

—

2.5e+00

9.5e-01

3.7e-01

cases:23.54%

controls:19.38%

cases:21.17%

controls:11.70%

cases:22.46%

controls:2.13%

—

cases:20.13%

controls:1.94%

cases:25.55%

controls:11.67%

cases:27.82%

controls:20.98%

109

891

354

3707

538

365

4060

104

359

4500

—

369

4503

116

530

338

4011

111

832

288

3134

Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]

1.2e+00

1.9e+00

—

1.0e+50

—

1.8e+00

cases:3.24%

controls:1.02%

cases:1.94%

controls:0.28%

—

cases:3.89%

controls:0.00%

—

cases:2.20%

controls:0.37%

cases:5.01%

controls:0.83%

448

4551

454

4585

—

445

4598

—

444

4524

379

3933

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

3.2e-01

8.7e-01

2.4e+00

—

1.8e+00

1.0e+00

7.0e-01

cases:13.39%

controls:10.09%

cases:9.07%

controls:4.02%

cases:6.70%

controls:0.67%

—

cases:3.90%

controls:0.68%

cases:11.01%

controls:4.27%

cases:16.04%

controls:8.65%

464

401

4134

185

421

4413

432

4567

—

444

4561

194

404

4347

343

335

3623

Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]

7.0e-01

2.1e+00

3.0e+00

—

1.6e+00

1.1e+00

cases:1.94%

controls:0.98%

cases:3.24%

controls:0.41%

cases:2.59%

controls:0.13%

—

cases:2.20%

controls:0.44%

cases:2.76%

controls:0.96%

454

4553

448

4579

451

4592

—

444

4521

388

3928

Blood type and Crossmatch panel - Blood
34531-4 [3044640]

2.0e-01

1.0e+00

2.6e+00

—

2.0e+00

1.1e+00

3.8e-01

cases:4.54%

controls:3.74%

cases:4.10%

controls:1.48%

cases:1.94%

controls:0.15%

—

cases:1.30%

controls:0.17%

cases:3.52%

controls:1.26%

cases:4.51%

controls:3.13%

172

442

4426

444

4530

454

4591

—

456

4584

438

4484

124

381

3842

CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]

2.8e-01

8.8e-01

2.0e+00

1.0e+50

2.6e+00

1.2e+00

8.4e-01

cases:3.89%

controls:2.98%

cases:3.46%

controls:1.46%

cases:1.94%

controls:0.26%

cases:1.08%

controls:0.00%

cases:3.68%

controls:0.28%

cases:4.41%

controls:1.37%

cases:7.77%

controls:3.50%

137

445

4461

447

4531

454

4586

458

4598

445

4579

434

4479

139

368

3827

Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]

2.4e-01

6.2e-01

2.6e+00

—

2.5e+00

8.9e-01

2.7e-01

cases:25.49%

controls:21.16%

cases:25.05%

controls:15.20%

cases:25.92%

controls:2.52%

—

cases:24.24%

controls:2.55%

cases:30.84%

controls:15.48%

cases:30.08%

controls:24.74%

118

973

345

3625

116

699

347

3899

120

116

343

4482

—

112

117

350

4475

140

703

314

3838

120

981

279

2985

pH of Venous blood
2746-6 [3012544]

1.2e+00

2.1e+00

—

1.0e+50

—

2.1e+00

1.2e+00

cases:2.81%

controls:0.83%

cases:2.81%

controls:0.37%

—

cases:1.08%

controls:0.00%

—

cases:3.08%

controls:0.40%

cases:4.01%

controls:1.21%

450

4560

450

4581

—

458

4598

—

440

4523

383

3918

disulfiram; oral
N07BB01 [21604821]

2.1e+00

2.6e+00

—

1.8e+00

cases:4.32%

controls:0.54%

cases:2.38%

controls:0.17%

—

cases:3.51%

controls:0.58%

443

4573

452

4590

—

385

3943

Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]

1.4e+00

2.2e+00

—

1.0e+50

—

1.7e+00

1.2e+00

cases:2.59%

controls:0.63%

cases:2.59%

controls:0.30%

—

cases:1.08%

controls:0.00%

—

cases:1.98%

controls:0.35%

cases:3.51%

controls:1.06%

451

4569

451

4584

—

458

4598

—

445

4525

385

3924

Neutrophils/Leukocytes in Blood
26511-6 [3018010]

3.7e-01

5.8e-01

1.8e+00

—

2.6e+00

1.2e+00

8.5e-01

cases:10.15%

controls:7.24%

cases:6.48%

controls:3.72%

cases:4.54%

controls:0.76%

—

cases:8.01%

controls:0.63%

cases:11.01%

controls:3.44%

cases:15.29%

controls:7.19%

333

416

4265

171

433

4427

442

4563

—

425

4563

156

404

4385

285

338

3681

Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]

2.8e-01

6.8e-01

2.2e+00

—

2.4e+00

7.9e-01

4.9e-01

cases:14.47%

controls:11.37%

cases:9.94%

controls:5.28%

cases:6.05%

controls:0.72%

—

cases:7.58%

controls:0.76%

cases:11.67%

controls:5.66%

cases:16.79%

controls:10.97%

523

396

4075

243

417

4355

435

4565

—

427

4557

257

401

4284

435

332

3531

levomepromazine; oral, parenteral
N05AA02 [21604493]

2.5e+00

1.5e+00

-1.0e+50

—

1.8e+00

2.3e+00

cases:3.67%

controls:0.33%

cases:1.08%

controls:0.24%

cases:0.00%

controls:0.11%

—

cases:1.54%

controls:0.26%

cases:4.26%

controls:0.45%

446

4583

458

4587

463

4593

—

447

4529

382

3948

alprazolam; oral
N05BA12 [21604577]

1.6e+00

1.7e+00

2.3e+00

—

1.8e+00

1.4e+00

cases:4.54%

controls:0.91%

cases:2.38%

controls:0.46%

cases:1.08%

controls:0.11%

—

cases:2.86%

controls:0.51%

cases:4.76%

controls:1.24%

442

4556

452

4577

458

4593

—

441

4518

380

3917

Depressive episode, unspecified
F32.9 [45571760]

1.6e+00

1.9e+00

2.1e+00

—

1.6e+00

1.3e+00

cases:5.40%

controls:1.17%

cases:3.89%

controls:0.59%

cases:1.08%

controls:0.13%

—

cases:3.08%

controls:0.62%

cases:5.01%

controls:1.46%

438

4544

445

4571

458

4592

—

440

4513

379

3908

Supplier / Service Provider
OMOP5117446 [33004]

-1.3e+00

-1.6e+00

—

2.3e+00

3.6e+00

3.3e+00

cases:11.66%

controls:32.51%

cases:2.81%

controls:12.92%

—

cases:1.30%

controls:0.13%

cases:5.29%

controls:0.15%

cases:9.77%

controls:0.38%

1495

409

3103

594

450

4004

—

456

4586

430

4534

360

3951

Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]

1.2e+00

2.0e+00

—

1.0e+50

—

1.8e+00

1.2e+00

cases:2.59%

controls:0.78%

cases:2.81%

controls:0.39%

—

cases:1.30%

controls:0.00%

—

cases:2.64%

controls:0.44%

cases:4.01%

controls:1.21%

451

4562

450

4580

—

457

4598

—

442

4521

383

3918

Ketones [Presence] in Urine by Test strip
2514-8 [3035350]

3.7e-01

7.1e-01

2.2e+00

—

1.9e+00

7.1e-01

5.7e-01

cases:9.50%

controls:6.76%

cases:6.70%

controls:3.39%

cases:5.40%

controls:0.61%

—

cases:2.60%

controls:0.39%

cases:7.49%

controls:3.83%

cases:12.28%

controls:7.36%

311

419

4287

156

432

4442

438

4570

—

450

4574

174

420

4367

292

350

3674

risperidone; oral, parenteral
N05AX08 [21604559]

1.2e+00

1.8e+00

—

2.2e+00

2.1e+00

cases:2.59%

controls:0.80%

cases:1.94%

controls:0.33%

—

cases:2.64%

controls:0.31%

cases:4.26%

controls:0.53%

451

4561

454

4583

—

442

4527

382

3945

lactulose; oral
A06AD11 [21600571]

1.9e+00

2.0e+00

—

2.2e+00

1.2e+00

cases:2.59%

controls:0.41%

cases:1.51%

controls:0.22%

—

cases:2.20%

controls:0.24%

cases:1.75%

controls:0.55%

451

4579

456

4588

—

444

4530

392

3944

Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]

-1.1e-01

9.7e-01

3.0e+00

—

3.0e+00

8.8e-01

8.2e-02

cases:3.24%

controls:3.59%

cases:2.81%

controls:1.09%

cases:2.59%

controls:0.13%

—

cases:3.03%

controls:0.15%

cases:2.20%

controls:0.92%

cases:4.01%

controls:3.71%

165

448

4433

450

4548

451

4592

—

448

4585

444

4499

147

383

3819

Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]

7.7e-01

6.0e-01

2.5e+00

—

2.7e+00

9.2e-01

6.0e-01

cases:5.62%

controls:2.68%

cases:2.59%

controls:1.44%

cases:1.30%

controls:0.11%

—

cases:1.95%

controls:0.13%

cases:3.08%

controls:1.26%

cases:4.76%

controls:2.67%

123

437

4475

451

4532

457

4593

—

453

4586

440

4484

106

380

3860

pH of Urine
2756-5 [3015736]

5.2e-01

9.9e-01

2.2e+00

1.0e+50

2.1e+00

7.6e-01

6.6e-01

cases:8.42%

controls:5.20%

cases:6.70%

controls:2.59%

cases:4.10%

controls:0.46%

cases:1.73%

controls:0.00%

cases:2.38%

controls:0.30%

cases:5.51%

controls:2.66%

cases:10.03%

controls:5.42%

239

424

4359

119

432

4479

444

4577

455

4598

451

4578

121

429

4420

215

359

3751

Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]

5.5e-01

9.5e-01

2.5e+00

—

2.4e+00

9.5e-01

1.0e+00

cases:5.83%

controls:3.44%

cases:3.24%

controls:1.28%

cases:1.51%

controls:0.13%

—

cases:1.73%

controls:0.15%

cases:2.86%

controls:1.12%

cases:9.27%

controls:3.48%

158

436

4440

448

4539

456

4592

—

454

4585

441

4490

138

362

3828

Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]

7.4e-01

1.6e+00

—

2.5e+00

1.9e+00

9.3e-01

cases:3.24%

controls:1.57%

cases:2.81%

controls:0.61%

—

cases:1.52%

controls:0.13%

cases:3.52%

controls:0.53%

cases:4.01%

controls:1.61%

448

4526

450

4570

—

455

4586

438

4517

383

3902

Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]

3.3e-01

8.3e-01

2.3e+00

—

1.9e+00

8.4e-01

5.8e-01

cases:8.21%

controls:6.05%

cases:5.18%

controls:2.33%

cases:1.94%

controls:0.20%

—

cases:1.95%

controls:0.28%

cases:4.63%

controls:2.05%

cases:8.52%

controls:4.97%

278

425

4320

107

439

4491

454

4589

—

453

4579

433

4448

197

365

3769

Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]

1.1e+00

2.0e+00

—

1.4e+00

1.3e+00

cases:3.02%

controls:0.98%

cases:3.24%

controls:0.43%

—

cases:2.42%

controls:0.59%

cases:4.76%

controls:1.41%

449

4553

448

4578

—

443

4514

380

3910

Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]

6.1e-01

1.1e+00

3.4e+00

—

1.3e+00

5.3e-01

cases:2.81%

controls:1.54%

cases:2.81%

controls:0.96%

cases:3.24%

controls:0.11%

—

cases:3.08%

controls:0.90%

cases:3.51%

controls:2.09%

450

4527

450

4554

448

4593

—

440

4500

385

3883

aripiprazole; oral, parenteral
N05AX12 [21604562]

1.2e+00

1.6e+00

—

1.4e+00

1.5e+00

cases:2.81%

controls:0.83%

cases:2.59%

controls:0.54%

—

cases:2.42%

controls:0.62%

cases:3.51%

controls:0.83%

450

4560

451

4573

—

443

4513

385

3933

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

3.6e-01

5.8e-01

2.2e+00

—

2.8e+00

6.8e-01

2.9e-01

cases:8.21%

controls:5.85%

cases:5.40%

controls:3.09%

cases:3.89%

controls:0.46%

—

cases:5.19%

controls:0.35%

cases:7.27%

controls:3.83%

cases:9.77%

controls:7.49%

269

425

4329

142

438

4456

445

4577

—

438

4576

174

421

4367

297

360

3669

CBC panel - Blood by Automated count
58410-2 [40761511]

2.6e-01

4.8e-01

2.1e+00

—

2.4e+00

6.6e-01

1.4e-01

cases:24.84%

controls:20.31%

cases:19.87%

controls:13.35%

cases:15.33%

controls:2.15%

—

cases:16.45%

controls:1.83%

cases:22.47%

controls:13.04%

cases:25.56%

controls:23.00%

115

934

348

3664

614

371

3984

392

4499

—

386

4508

102

592

352

3949

102

912

297

3054

Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]

2.9e-01

6.4e-01

2.0e+00

—

1.6e+00

7.9e-01

5.0e-01

cases:14.04%

controls:10.92%

cases:9.07%

controls:4.98%

cases:5.62%

controls:0.76%

—

cases:3.03%

controls:0.63%

cases:9.91%

controls:4.73%

cases:15.04%

controls:9.66%

502

398

4096

229

421

4369

437

4563

—

448

4563

215

409

4326

383

339

3583

Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]

3.5e-01

6.8e-01

2.3e+00

1.0e+50

1.9e+00

7.6e-01

5.8e-01

cases:9.29%

controls:6.70%

cases:6.48%

controls:3.39%

cases:5.62%

controls:0.59%

cases:2.59%

controls:0.00%

cases:2.60%

controls:0.39%

cases:7.71%

controls:3.74%

cases:12.28%

controls:7.24%

308

420

4290

156

433

4442

437

4571

451

4598

450

4574

170

419

4371

287

350

3679

Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]

7.2e-01

1.9e+00

—

1.0e+50

—

2.3e+00

1.4e+00

cases:2.59%

controls:1.28%

cases:3.02%

controls:0.48%

—

cases:4.10%

controls:0.00%

—

cases:3.74%

controls:0.40%

cases:4.26%

controls:1.13%

451

4539

449

4576

—

444

4598

—

437

4523

382

3921

valproic acid; oral, parenteral, rectal
N03AG01 [21604422]

1.9e+00

1.8e+00

—

8.3e-01

1.8e+00

cases:3.46%

controls:0.54%

cases:2.81%

controls:0.46%

—

cases:1.10%

controls:0.48%

cases:4.51%

controls:0.81%

447

4573

450

4577

—

449

4519

381

3934

Glucose [Presence] in Urine by Test strip
25428-4 [3009261]

3.4e-01

6.6e-01

2.2e+00

—

2.0e+00

7.2e-01

5.5e-01

cases:9.72%

controls:7.09%

cases:6.70%

controls:3.59%

cases:5.40%

controls:0.61%

—

cases:2.60%

controls:0.37%

cases:7.71%

controls:3.92%

cases:12.28%

controls:7.46%

326

418

4272

165

432

4433

438

4570

—

450

4575

178

419

4363

296

350

3670

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

3.7e-01

7.4e-01

2.1e+00

1.0e+50

1.8e+00

8.9e-01

7.1e-01

cases:8.21%

controls:5.83%

cases:5.18%

controls:2.54%

cases:3.46%

controls:0.43%

cases:2.16%

controls:0.00%

cases:1.73%

controls:0.30%

cases:6.17%

controls:2.62%

cases:9.77%

controls:5.07%

268

425

4330

117

439

4481

447

4578

453

4598

454

4578

119

426

4422

201

360

3765

Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]

2.0e-01

5.4e-01

2.5e+00

1.0e+50

2.2e+00

8.0e-01

7.6e-01

cases:4.97%

controls:4.09%

cases:3.02%

controls:1.78%

cases:2.59%

controls:0.22%

cases:1.51%

controls:0.00%

cases:1.30%

controls:0.15%

cases:4.19%

controls:1.92%

cases:7.27%

controls:3.53%

188

440

4410

449

4516

451

4588

456

4598

456

4585

435

4454

140

370

3826

Social worker
Z2446 [2001311559]

1.1e+00

—

2.5e+00

2.9e+00

cases:1.73%

controls:0.61%

—

cases:1.32%

controls:0.11%

cases:3.01%

controls:0.18%

455

4570

—

448

4536

387

3959

Base excess in Venous blood by calculation
1927-3 [3002032]

1.1e+00

2.1e+00

—

1.9e+00

1.3e+00

cases:2.38%

controls:0.80%

cases:2.81%

controls:0.35%

—

cases:2.64%

controls:0.42%

cases:4.01%

controls:1.13%

452

4561

450

4582

—

442

4522

383

3921

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

1.8e-01

5.2e-01

2.1e+00

—

2.1e+00

5.4e-01

1.1e-01

cases:21.60%

controls:18.68%

cases:20.30%

controls:13.14%

cases:17.49%

controls:2.65%

—

cases:16.23%

controls:2.33%

cases:21.37%

controls:13.70%

cases:24.31%

controls:22.34%

100

859

363

3739

604

369

3994

122

382

4476

—

107

387

4485

622

357

3919

886

302

3080

Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]

1.6e+00

1.9e+00

—

1.8e+00

1.3e+00

cases:1.94%

controls:0.41%

cases:1.51%

controls:0.24%

—

cases:1.54%

controls:0.26%

cases:2.76%

controls:0.78%

454

4579

456

4587

—

447

4529

388

3935

mirtazapine; oral
N06AX11 [21604740]

1.4e+00

1.3e+00

1.2e+00

—

1.2e+00

1.4e+00

1.2e+00

cases:12.96%

controls:3.70%

cases:5.83%

controls:1.70%

cases:1.30%

controls:0.39%

—

cases:1.52%

controls:0.46%

cases:6.39%

controls:1.70%

cases:10.03%

controls:3.33%

170

403

4428

436

4520

457

4580

—

455

4571

425

4464

132

359

3834

magnesium hydroxide; oral
A02AA04 [21600052]

2.6e+00

—

2.3e+00

2.5e+00

cases:1.51%

controls:0.11%

—

cases:1.10%

controls:0.11%

cases:1.50%

controls:0.13%

456

4593

—

449

4536

393

3961

magnesium hydroxide; oral
G04BX01 [21602658]

2.6e+00

—

2.3e+00

2.5e+00

cases:1.51%

controls:0.11%

—

cases:1.10%

controls:0.11%

cases:1.50%

controls:0.13%

456

4593

—

449

4536

393

3961

pantoprazole; oral, parenteral
A02BC02 [21600097]

4.6e-01

7.8e-01

1.4e+00

—

1.3e+00

8.5e-01

6.7e-01

cases:14.25%

controls:9.46%

cases:10.15%

controls:4.92%

cases:3.67%

controls:0.89%

—

cases:4.11%

controls:1.11%

cases:10.79%

controls:4.93%

cases:15.29%

controls:8.45%

435

397

4163

226

416

4372

446

4557

—

443

4541

224

405

4317

335

338

3631

Case Management Agency
251B00000X [38004193]

7.6e-02

2.3e-01

9.8e-01

3.4e+00

6.6e-01

2.9e-01

1.5e-01

cases:44.28%

controls:42.41%

cases:41.47%

controls:36.06%

cases:30.45%

controls:14.14%

cases:20.95%

controls:0.85%

cases:26.19%

controls:15.53%

cases:44.05%

controls:37.13%

cases:47.87%

controls:44.25%

205

1950

258

2648

192

1658

271

2940

141

650

322

3948

366

4559

121

713

341

3879

200

1686

254

2855

191

1755

208

2211

citalopram; oral, parenteral
N06AB04 [21604712]

1.2e+00

—

1.4e+00

1.3e+00

cases:5.18%

controls:1.57%

cases:3.24%

controls:1.00%

—

cases:1.30%

controls:0.33%

cases:3.52%

controls:0.99%

cases:7.52%

controls:2.14%

439

4526

448

4552

—

456

4577

438

4496

369

3881

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]

2.7e+00

—

2.3e+00

cases:4.32%

controls:0.30%

—

cases:3.26%

controls:0.33%

443

4584

—

386

3953

Protein [Presence] in Urine by Test strip
20454-5 [3014051]

5.7e-02

6.0e-01

2.5e+00

—

2.5e+00

4.8e-01

2.1e-01

cases:3.24%

controls:3.07%

cases:3.24%

controls:1.81%

cases:2.81%

controls:0.24%

—

cases:1.52%

controls:0.13%

cases:2.64%

controls:1.65%

cases:4.76%

controls:3.88%

141

448

4457

448

4515

450

4587

—

455

4586

442

4466

154

380

3812

Schizophrenia, unspecified
F20.9 [45576533]

2.3e+00

—

2.6e+00

cases:1.51%

controls:0.15%

—

cases:2.76%

controls:0.20%

456

4591

—

388

3958

Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]

2.2e+00

—

2.7e+00

1.8e+00

cases:1.73%

controls:0.20%

—

cases:1.54%

controls:0.11%

cases:1.50%

controls:0.25%

455

4589

—

447

4536

393

3956

buspirone; oral
N05BE01 [21604601]

2.6e+00

—

2.2e+00

cases:1.73%

controls:0.13%

—

cases:2.01%

controls:0.23%

455

4592

—

391

3957

Pain localized to upper abdomen
R10.1 [45568111]

1.0e+00

9.2e-01

—

1.0e+50

—

2.1e+00

1.7e+00

cases:3.46%

controls:1.30%

cases:1.30%

controls:0.52%

—

cases:1.51%

controls:0.00%

—

cases:2.86%

controls:0.35%

cases:4.51%

controls:0.88%

447

4538

457

4574

—

456

4598

—

441

4525

381

3931

Myelocytes/Leukocytes in Blood
26498-6 [3017181]

—

6.5e-01

—

3.1e+00

1.7e+00

1.0e+00

—

cases:1.08%

controls:0.57%

—

cases:2.81%

controls:0.13%

cases:2.20%

controls:0.42%

cases:3.01%

controls:1.11%

—

458

4572

—

449

4586

444

4522

387

3922

propranolol; oral, parenteral
C07AA05 [21601670]

1.3e+00

1.4e+00

—

1.3e+00

8.6e-01

1.2e+00

cases:10.80%

controls:3.20%

cases:7.34%

controls:1.91%

cases:1.51%

controls:0.39%

—

cases:1.30%

controls:0.35%

cases:4.63%

controls:2.00%

cases:10.53%

controls:3.40%

147

413

4451

429

4510

456

4580

—

456

4576

433

4450

135

357

3831

Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]

—

2.6e+00

—

2.2e+00

1.4e+00

—

cases:1.94%

controls:0.15%

—

cases:1.76%

controls:0.20%

cases:2.01%

controls:0.50%

—

454

4591

—

446

4532

391

3946

Promyelocytes/Leukocytes in Blood
26524-9 [3021440]

—

3.0e+00

1.7e+00

1.0e+00

—

cases:2.60%

controls:0.13%

cases:2.20%

controls:0.40%

cases:3.01%

controls:1.08%

—

450

4586

444

4523

387

3923

Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]

1.6e+00

2.5e+00

—

2.2e+00

cases:1.51%

controls:0.30%

cases:1.30%

controls:0.11%

—

cases:2.01%

controls:0.23%

456

4584

457

4593

—

391

3957

Paranoid schizophrenia continuous
F20.00 [2000501920]

2.6e+00

—

2.1e+00

cases:1.94%

controls:0.15%

—

cases:2.26%

controls:0.28%

454

4591

—

390

3955

Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]

4.5e-01

6.9e-01

2.0e+00

—

2.6e+00

7.8e-01

4.4e-01

cases:6.05%

controls:3.94%

cases:3.89%

controls:1.98%

cases:1.73%

controls:0.24%

—

cases:1.73%

controls:0.13%

cases:4.85%

controls:2.29%

cases:7.27%

controls:4.79%

181

435

4417

445

4507

455

4587

—

454

4586

104

432

4437

190

370

3776

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

5.2e-01

6.3e-01

2.3e+00

1.0e+50

2.3e+00

7.0e-01

5.0e-01

cases:6.91%

controls:4.24%

cases:3.46%

controls:1.87%

cases:3.24%

controls:0.35%

cases:2.59%

controls:0.00%

cases:2.16%

controls:0.22%

cases:3.30%

controls:1.67%

cases:6.27%

controls:3.91%

195

431

4403

447

4512

448

4582

451

4598

452

4582

439

4465

155

374

3811

cefalexin; oral
J01DB01 [21602870]

3.2e-01

8.8e-01

1.4e+00

—

1.6e+00

5.4e-01

6.9e-01

cases:24.41%

controls:19.03%

cases:13.61%

controls:6.13%

cases:2.59%

controls:0.65%

—

cases:3.46%

controls:0.72%

cases:9.47%

controls:5.77%

cases:36.09%

controls:22.01%

113

875

350

3723

282

400

4316

451

4568

—

446

4559

262

411

4279

144

873

255

3093

zopiclone; oral
N05CF01 [21604654]

1.1e+00

9.7e-01

1.2e+00

—

1.2e+00

1.3e+00

cases:8.64%

controls:3.02%

cases:4.75%

controls:1.85%

cases:1.51%

controls:0.46%

—

cases:1.95%

controls:0.61%

cases:5.29%

controls:1.72%

cases:11.53%

controls:3.43%

139

423

4459

441

4513

456

4577

—

453

4564

430

4463

136

353

3830

hydroxyzine; oral, parenteral
N05BB01 [21604590]

1.4e+00

8.0e-01

—

1.5e+00

1.6e+00

cases:5.62%

controls:1.41%

cases:1.30%

controls:0.59%

—

cases:2.86%

controls:0.66%

cases:7.02%

controls:1.46%

437

4533

457

4571

—

441

4511

371

3908

Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]

1.9e+00

2.4e+00

—

1.7e+00

1.2e+00

cases:1.51%

controls:0.24%

cases:1.94%

controls:0.17%

—

cases:1.10%

controls:0.20%

cases:1.50%

controls:0.48%

456

4587

454

4590

—

449

4532

393

3947

Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]

1.8e+00

2.4e+00

—

1.6e+00

9.7e-01

cases:1.51%

controls:0.26%

cases:1.94%

controls:0.17%

—

cases:1.10%

controls:0.22%

cases:1.25%

controls:0.48%

456

4586

454

4590

—

449

4531

394

3947

Bipolar affective disorder, unspecified
F31.9 [45571758]

2.1e+00

—

2.0e+00

cases:2.16%

controls:0.26%

—

cases:2.01%

controls:0.28%

453

4586

—

391

3955

Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]

7.2e-01

1.1e+00

—

1.7e+00

2.3e+00

cases:2.16%

controls:1.07%

cases:1.51%

controls:0.50%

—

cases:2.42%

controls:0.44%

cases:4.76%

controls:0.48%

453

4549

456

4575

—

443

4521

380

3947

Albumin [Presence] in Urine by Test strip
50949-7 [3029937]

5.6e-01

8.4e-01

2.3e+00

1.0e+50

1.5e+00

9.1e-01

8.8e-01

cases:6.91%

controls:4.07%

cases:3.89%

controls:1.72%

cases:3.24%

controls:0.35%

cases:1.94%

controls:0.00%

cases:1.08%

controls:0.24%

cases:5.29%

controls:2.20%

cases:8.27%

controls:3.61%

187

431

4411

445

4519

448

4582

454

4598

457

4581

100

430

4441

143

366

3823

Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]

1.1e+00

9.1e-01

—

2.9e+00

7.6e-01

6.7e-01

cases:4.75%

controls:1.63%

cases:3.02%

controls:1.24%

—

cases:1.95%

controls:0.11%

cases:2.86%

controls:1.37%

cases:5.26%

controls:2.77%

441

4523

449

4541

—

453

4587

441

4479

110

378

3856

zolpidem; oral
N05CF02 [21604655]

8.2e-01

1.3e+00

—

1.4e+00

1.3e+00

cases:3.24%

controls:1.46%

cases:3.02%

controls:0.85%

—

cases:3.30%

controls:0.84%

cases:4.76%

controls:1.34%

448

4531

449

4559

—

439

4503

380

3913

Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]

1.1e+00

2.3e+00

—

1.0e+50

—

1.7e+00

cases:1.51%

controls:0.50%

cases:2.59%

controls:0.26%

—

cases:1.94%

controls:0.00%

cases:1.30%

controls:0.00%

—

cases:3.01%

controls:0.58%

456

4575

451

4586

—

454

4598

456

4592

—

387

3943

clindamycin; oral, parenteral
J01FF01 [21602985]

1.1e+00

7.3e-01

—

1.4e+00

cases:5.40%

controls:1.83%

cases:1.08%

controls:0.52%

—

cases:2.20%

controls:0.53%

cases:7.52%

controls:2.02%

438

4514

458

4574

—

444

4517

369

3886

Abdominal ultrasound examination
JN3AE [2001305555]

6.7e-01

—

1.0e+50

—

2.1e+00

1.8e+00

cases:1.94%

controls:1.00%

—

cases:3.02%

controls:0.00%

—

cases:1.76%

controls:0.22%

cases:2.76%

controls:0.45%

454

4552

—

449

4598

—

446

4531

388

3948

Osmolality of Urine
2695-5 [3026782]

6.5e-01

1.2e-01

2.7e+00

1.0e+50

—

1.2e+00

5.8e-01

cases:4.54%

controls:2.41%

cases:1.08%

controls:0.96%

cases:2.16%

controls:0.15%

cases:1.73%

controls:0.00%

—

cases:2.64%

controls:0.79%

cases:2.76%

controls:1.56%

111

442

4487

458

4554

453

4591

455

4598

—

442

4505

388

3904

Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]

1.0e+00

2.2e+00

1.0e+50

—

1.1e+00

1.7e+00

cases:1.94%

controls:0.72%

cases:1.73%

controls:0.20%

cases:1.30%

controls:0.00%

—

cases:1.10%

controls:0.35%

cases:4.26%

controls:0.81%

454

4565

455

4589

457

4598

—

449

4525

382

3934

Bacteria identified in Urine by Culture
630-4 [3026008]

6.7e-01

7.0e-01

1.8e+00

—

1.6e+00

1.2e+00

9.1e-01

cases:6.48%

controls:3.44%

cases:3.02%

controls:1.52%

cases:1.94%

controls:0.33%

—

cases:1.30%

controls:0.26%

cases:5.07%

controls:1.63%

cases:7.52%

controls:3.18%

158

433

4440

449

4528

454

4583

—

456

4580

431

4467

126

369

3840

IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]

8.5e-01

2.5e+00

—

1.0e+50

—

1.4e+00

1.3e+00

cases:2.16%

controls:0.94%

cases:3.67%

controls:0.30%

—

cases:1.08%

controls:0.00%

—

cases:1.98%

controls:0.51%

cases:2.76%

controls:0.73%

453

4555

446

4584

—

458

4598

—

445

4518

388

3937

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

9.8e-01

5.4e-01

—

1.5e+00

1.4e+00

cases:4.10%

controls:1.59%

cases:1.08%

controls:0.63%

—

cases:2.42%

controls:0.55%

cases:5.51%

controls:1.49%

444

4525

458

4569

—

443

4516

377

3907

Albumin [Mass/volume] in Urine
1754-1 [3012516]

9.1e-01

6.7e-01

2.9e+00

—

2.9e-01

1.9e-01

cases:7.99%

controls:3.39%

cases:4.75%

controls:2.48%

cases:2.59%

controls:0.15%

—

cases:3.74%

controls:2.82%

cases:6.27%

controls:5.22%

156

426

4442

114

441

4484

451

4591

—

128

437

4413

207

374

3759

semaglutide; oral, parenteral
A10BJ06 [1501778]

2.0e+00

1.8e+00

—

9.3e-01

7.8e-02

cases:1.73%

controls:0.24%

cases:1.51%

controls:0.26%

—

cases:1.54%

controls:0.62%

cases:1.25%

controls:1.16%

455

4587

456

4586

—

447

4513

394

3920

Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]

1.8e+00

2.0e+00

—

1.0e+50

1.4e+00

1.2e+00

cases:1.51%

controls:0.26%

cases:1.51%

controls:0.22%

—

cases:1.30%

controls:0.00%

cases:1.10%

controls:0.29%

cases:2.26%

controls:0.71%

456

4586

456

4588

—

456

4592

449

4528

390

3938

melatonin; oral
N05CH01 [21604659]

1.1e+00

1.4e+00

—

1.4e+00

1.1e+00

7.0e-01

cases:4.97%

controls:1.65%

cases:3.89%

controls:0.96%

—

cases:1.30%

controls:0.33%

cases:3.52%

controls:1.21%

cases:4.76%

controls:2.42%

440

4522

445

4554

—

456

4577

438

4486

380

3870

Remote contact by phone
ZYC01 [2001311579]

1.7e+00

—

2.0e+00

1.1e+00

cases:1.94%

controls:0.37%

—

cases:1.54%

controls:0.22%

cases:2.01%

controls:0.66%

454

4581

—

447

4531

391

3940

perphenazine; oral, parenteral, rectal
N05AB03 [21604502]

1.9e+00

1.7e+00

—

1.1e+00

cases:2.38%

controls:0.35%

cases:1.73%

controls:0.33%

—

cases:1.50%

controls:0.50%

452

4582

455

4583

—

393

3946

12 lead EKG panel
34534-8 [3044889]

4.1e-01

3.4e-01

1.5e+00

—

1.6e+00

1.9e-01

5.1e-01

cases:14.47%

controls:10.13%

cases:7.13%

controls:5.20%

cases:2.81%

controls:0.65%

—

cases:2.16%

controls:0.44%

cases:5.95%

controls:4.95%

cases:16.29%

controls:10.49%

466

396

4132

239

430

4359

450

4568

—

452

4572

225

427

4316

416

334

3550

Hepatitis B virus surface Ab [Units/volume] in Serum
16935-9 [3023421]

1.7e+00

—

1.9e+00

cases:2.38%

controls:0.43%

—

cases:3.01%

controls:0.48%

452

4578

—

387

3947

Medical abortion, complete or unspecified, without complication
O04.9 [45543909]

1.8e+00

-1.0e+50

—

1.8e+00

cases:2.59%

controls:0.43%

cases:0.00%

controls:0.13%

—

cases:4.26%

controls:0.76%

451

4578

463

4592

—

382

3936

Asthma, unspecified
J45.9 [45562456]

9.1e-01

1.4e+00

—

1.0e+50

2.0e+00

1.3e+00

6.7e-01

cases:4.10%

controls:1.70%

cases:2.38%

controls:0.61%

—

cases:1.51%

controls:0.00%

cases:1.08%

controls:0.15%

cases:2.64%

controls:0.75%

cases:3.76%

controls:1.97%

444

4520

452

4570

—

456

4598

457

4585

442

4507

384

3888

antibiotics in combination with corticosteroids
D01AA20 [21601918]

8.0e-01

—

2.0e+00

1.4e+00

cases:2.16%

controls:0.98%

—

cases:1.32%

controls:0.18%

cases:3.51%

controls:0.88%

453

4553

—

448

4533

385

3931

lamotrigine; oral
N03AX09 [21604431]

1.7e+00

1.6e+00

—

1.5e+00

1.7e+00

cases:2.38%

controls:0.46%

cases:1.08%

controls:0.22%

—

cases:1.32%

controls:0.31%

cases:3.26%

controls:0.61%

452

4577

458

4588

—

448

4527

386

3942

Abdominal CT examination
JN3AD [2001305554]

1.3e+00

—

1.0e+50

—

2.0e+00

1.3e+00

cases:1.73%

controls:0.50%

—

cases:2.81%

controls:0.00%

cases:2.16%

controls:0.00%

—

cases:2.20%

controls:0.31%

cases:2.76%

controls:0.73%

455

4575

—

450

4598

453

4598

—

444

4527

388

3937

Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]

7.0e-01

6.0e-01

2.6e+00

—

3.5e-01

1.5e-01

cases:7.56%

controls:3.91%

cases:4.97%

controls:2.78%

cases:2.38%

controls:0.17%

—

cases:4.19%

controls:2.97%

cases:6.52%

controls:5.67%

180

428

4418

128

440

4470

452

4590

—

135

435

4406

225

373

3741

Thorax X-ray examination
GD1AA [2001303617]

8.4e-01

9.1e-01

—

1.0e+50

1.8e+00

1.2e+00

cases:8.86%

controls:4.02%

cases:3.24%

controls:1.33%

—

cases:3.46%

controls:0.00%

cases:1.30%

controls:0.22%

cases:4.63%

controls:1.41%

cases:9.52%

controls:3.10%

185

422

4413

448

4537

—

447

4598

456

4582

433

4477

123

361

3843

Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]

3.2e-01

4.0e-01

1.6e+00

—

1.7e+00

4.4e-01

1.5e-01

cases:20.95%

controls:16.12%

cases:12.96%

controls:9.05%

cases:5.18%

controls:1.13%

—

cases:3.90%

controls:0.76%

cases:13.88%

controls:9.43%

cases:20.30%

controls:18.05%

741

366

3857

416

403

4182

439

4546

—

444

4557

428

391

4113

716

318

3250

IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]

1.0e+00

3.2e+00

—

1.0e+50

—

1.4e+00

1.2e+00

cases:1.94%

controls:0.72%

cases:3.02%

controls:0.13%

—

cases:1.30%

controls:0.00%

—

cases:1.10%

controls:0.26%

cases:1.75%

controls:0.53%

454

4565

449

4592

—

457

4598

—

449

4529

392

3945

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

9.0e-01

1.9e+00

—

1.2e+00

cases:3.46%

controls:1.44%

cases:1.94%

controls:0.28%

—

cases:3.26%

controls:1.01%

447

4532

454

4585

—

386

3926

Anxiety disorder, unspecified
F41.9 [45542849]

1.6e+00

1.1e+00

—

9.3e-01

1.5e+00

cases:4.10%

controls:0.85%

cases:1.30%

controls:0.46%

—

cases:1.54%

controls:0.62%

cases:5.26%

controls:1.21%

444

4559

457

4577

—

447

4513

378

3918

Severe psychotic and other severe mental disorders
112 [2001600112]

1.2e+00

—

1.9e+00

cases:3.02%

controls:0.96%

—

cases:1.32%

controls:0.20%

cases:4.26%

controls:0.63%

449

4554

—

448

4532

382

3941

Hepatitis A virus IgM Ab [Presence] in Serum
22314-9 [3013327]

—

1.0e+50

—

3.1e+00

—

cases:3.46%

controls:0.00%

cases:4.55%

controls:0.00%

—

cases:2.76%

controls:0.13%

—

447

4598

441

4592

—

388

3961

paroxetine; oral
N06AB05 [21604713]

1.4e+00

—

-1.0e+50

—

-1.0e+50

9.7e-01

1.6e+00

cases:2.38%

controls:0.59%

—

cases:0.00%

controls:0.20%

—

cases:0.00%

controls:0.13%

cases:1.10%

controls:0.42%

cases:3.01%

controls:0.61%

452

4571

—

463

4589

—

462

4586

449

4522

387

3942

Diabetes non-insulin dependent
T90 [2002001131]

9.1e-01

8.9e-01

1.5e+00

—

1.7e+00

1.2e+00

9.0e-01

cases:4.97%

controls:2.07%

cases:3.67%

controls:1.54%

cases:1.51%

controls:0.35%

—

cases:1.52%

controls:0.28%

cases:4.63%

controls:1.41%

cases:5.51%

controls:2.32%

440

4503

446

4527

456

4582

—

455

4579

433

4477

377

3874

Administration of medicine
SPAT1254 [2001700355]

1.2e+00

—

-1.0e+50

1.1e+00

1.7e+00

cases:4.10%

controls:1.22%

—

cases:0.00%

controls:0.15%

cases:1.10%

controls:0.35%

cases:3.51%

controls:0.66%

444

4542

—

462

4585

449

4525

385

3940

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

2.4e-01

2.5e-01

1.4e+00

—

1.5e+00

4.2e-01

2.9e-01

cases:16.20%

controls:13.22%

cases:8.64%

controls:6.85%

cases:3.67%

controls:0.91%

—

cases:3.90%

controls:0.87%

cases:10.57%

controls:7.18%

cases:18.30%

controls:14.40%

608

388

3990

315

423

4283

446

4556

—

444

4552

326

406

4215

571

326

3395

chlordiazepoxide; oral, parenteral
N05BA02 [21604567]

2.9e+00

—

cases:2.38%

controls:0.13%

—

452

4592

—

Alcohol dependence currently independent
F10.20 [2000501677]

2.9e+00

—

cases:2.38%

controls:0.13%

—

452

4592

—

Hepatitis B virus core IgM Ab [Presence] in Serum
31204-1 [3013527]

1.6e+00

2.9e+00

1.0e+50

—

1.4e+00

cases:1.08%

controls:0.22%

cases:2.38%

controls:0.13%

cases:1.94%

controls:0.00%

cases:1.73%

controls:0.00%

cases:1.73%

controls:0.00%

—

cases:1.75%

controls:0.43%

458

4588

452

4592

454

4598

455

4598

454

4592

—

392

3949

Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]

8.2e-01

1.1e+00

—

9.3e-01

cases:6.26%

controls:2.87%

cases:3.67%

controls:1.26%

—

cases:2.86%

controls:1.15%

cases:7.27%

controls:3.00%

132

434

4466

446

4540

—

441

4489

119

370

3847

Medical doctor
Z2221 [2001311556]

4.9e-01

8.2e-01

—

1.4e+00

cases:3.89%

controls:2.41%

cases:1.51%

controls:0.67%

—

cases:2.64%

controls:0.64%

cases:5.26%

controls:1.36%

111

445

4487

456

4567

—

442

4512

378

3912

hydrocortisone buteprate
D07AB11 [21602115]

4.4e-01

9.3e-01

—

9.7e-01

9.0e-01

cases:7.13%

controls:4.70%

cases:3.67%

controls:1.48%

—

cases:3.52%

controls:1.37%

cases:12.28%

controls:5.37%

216

430

4382

446

4530

—

438

4479

213

350

3753

hydrocortisone butyrate
D07AB02 [21602106]

4.4e-01

9.3e-01

—

9.7e-01

9.0e-01

cases:7.13%

controls:4.70%

cases:3.67%

controls:1.48%

—

cases:3.52%

controls:1.37%

cases:12.28%

controls:5.37%

216

430

4382

446

4530

—

438

4479

213

350

3753

hydrocortisone aceponate
D07AC16 [21602135]

4.4e-01

9.3e-01

—

9.7e-01

9.0e-01

cases:7.13%

controls:4.70%

cases:3.67%

controls:1.48%

—

cases:3.52%

controls:1.37%

cases:12.28%

controls:5.37%

216

430

4382

446

4530

—

438

4479

213

350

3753

hydrocortisone
D07AA02 [21602102]

4.4e-01

9.3e-01

—

9.7e-01

9.0e-01

cases:7.13%

controls:4.70%

cases:3.67%

controls:1.48%

—

cases:3.52%

controls:1.37%

cases:12.28%

controls:5.37%

216

430

4382

446

4530

—

438

4479

213

350

3753

Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]

1.4e+00

1.1e+00

—

9.7e-01

1.4e+00

cases:3.46%

controls:0.89%

cases:1.51%

controls:0.52%

—

cases:1.32%

controls:0.51%

cases:4.26%

controls:1.08%

447

4557

456

4574

—

448

4518

382

3923

Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]

3.1e-01

6.1e-01

2.8e+00

1.0e+50

—

4.7e-01

3.6e-01

cases:3.24%

controls:2.39%

cases:1.94%

controls:1.07%

cases:1.73%

controls:0.11%

cases:1.94%

controls:0.00%

—

cases:1.54%

controls:0.97%

cases:3.01%

controls:2.12%

110

448

4488

454

4549

455

4593

454

4598

—

447

4497

387

3882

Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 [3004410]

2.9e-01

3.5e-01

1.6e+00

—

1.1e+00

3.3e-01

1.0e-01

cases:17.28%

controls:13.55%

cases:12.96%

controls:9.46%

cases:6.26%

controls:1.30%

—

cases:3.25%

controls:1.07%

cases:13.44%

controls:10.06%

cases:20.30%

controls:18.68%

623

383

3975

435

403

4163

434

4538

—

447

4543

457

393

4084

741

318

3225

Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]

7.3e-01

1.1e+00

—

8.4e-01

8.7e-01

cases:6.48%

controls:3.24%

cases:4.32%

controls:1.41%

—

cases:2.86%

controls:1.26%

cases:7.27%

controls:3.18%

149

433

4449

443

4533

—

441

4484

126

370

3840

fluoxetine; oral
N06AB03 [21604711]

1.4e+00

8.9e-01

-1.0e+50

—

9.8e-01

1.4e+00

cases:4.32%

controls:1.13%

cases:1.73%

controls:0.72%

cases:0.00%

controls:0.20%

—

cases:2.20%

controls:0.84%

cases:5.01%

controls:1.34%

443

4546

455

4565

463

4589

—

444

4503

379

3913

Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]

1.3e+00

1.2e+00

—

1.2e+00

1.4e+00

cases:3.24%

controls:0.87%

cases:1.51%

controls:0.48%

—

cases:1.32%

controls:0.42%

cases:4.01%

controls:1.03%

448

4558

456

4576

—

448

4522

383

3925

chlorprothixene; oral, parenteral
N05AF03 [21604533]

2.7e+00

—

1.5e+00

cases:2.59%

controls:0.17%

—

cases:1.50%

controls:0.35%

451

4590

—

393

3952

Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]

2.5e-01

3.6e-01

1.2e+00

—

1.4e+00

3.0e-01

2.3e-01

cases:20.73%

controls:16.86%

cases:12.74%

controls:9.26%

cases:4.54%

controls:1.37%

—

cases:4.55%

controls:1.11%

cases:13.00%

controls:10.00%

cases:22.56%

controls:18.84%

775

367

3823

426

404

4172

442

4535

—

441

4541

454

395

4087

747

309

3219

metformin; oral
A10BA02 [21600747]

1.0e+00

9.0e-01

5.8e-01

—

5.1e-01

7.5e-01

3.2e-01

cases:7.78%

controls:2.96%

cases:6.48%

controls:2.74%

cases:1.73%

controls:0.98%

—

cases:1.52%

controls:0.91%

cases:6.17%

controls:3.02%

cases:5.26%

controls:3.88%

136

427

4462

126

433

4472

455

4553

—

455

4550

137

426

4404

154

378

3812

IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]

2.0e-01

1.4e+00

—

1.0e+50

—

1.2e+00

4.7e-01

cases:3.46%

controls:2.85%

cases:3.67%

controls:0.91%

—

cases:1.30%

controls:0.00%

—

cases:2.86%

controls:0.86%

cases:4.26%

controls:2.70%

131

447

4467

446

4556

—

457

4598

—

441

4502

107

382

3859

Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]

1.5e+00

—

1.0e+50

—

2.6e+00

cases:1.08%

controls:0.24%

—

cases:3.24%

controls:0.00%

cases:5.19%

controls:0.00%

—

cases:3.01%

controls:0.23%

458

4587

—

448

4598

438

4592

—

387

3957

Laparoscopic cholecystectomy
JKA21 [2001305294]

—

2.6e+00

1.7e+00

—

cases:1.76%

controls:0.13%

cases:1.50%

controls:0.28%

—

446

4535

393

3955

Pharmacy visit
OMOP4822462 [581458]

2.5e-02

1.7e-01

4.9e-01

9.6e-01

6.4e-01

5.0e-01

3.8e-01

cases:68.47%

controls:67.92%

cases:65.01%

controls:61.03%

cases:38.01%

controls:27.23%

cases:4.10%

controls:1.61%

cases:41.13%

controls:26.85%

cases:74.45%

controls:63.97%

cases:91.23%

controls:87.70%

317

3123

146

1475

301

2806

162

1792

176

1252

287

3346

444

4524

190

1233

272

3359

338

2905

116

1636

364

3478

488

prednisolone; oral, parenteral
H02AB06 [21602734]

6.2e-01

3.5e-01

—

2.0e+00

6.0e-01

5.2e-01

cases:9.50%

controls:5.37%

cases:3.24%

controls:2.31%

—

cases:2.16%

controls:0.30%

cases:3.96%

controls:2.22%

cases:8.52%

controls:5.24%

247

419

4351

106

448

4492

—

452

4578

101

436

4440

208

365

3758

prednisolone
A07EA01 [21600653]

6.1e-01

4.2e-01

—

2.0e+00

5.9e-01

5.4e-01

cases:9.50%

controls:5.42%

cases:3.46%

controls:2.31%

—

cases:2.16%

controls:0.30%

cases:3.96%

controls:2.25%

cases:8.77%

controls:5.32%

249

419

4349

106

447

4492

—

452

4578

102

436

4439

211

364

3755

Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]

1.7e-01

2.1e-01

1.3e+00

—

1.2e+00

1.3e-01

-1.0e-01

cases:18.79%

controls:16.40%

cases:10.58%

controls:8.74%

cases:3.46%

controls:0.94%

—

cases:3.03%

controls:0.89%

cases:9.69%

controls:8.61%

cases:17.54%

controls:19.04%

754

376

3844

402

414

4196

447

4555

—

448

4551

391

410

4150

755

329

3211

Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]

—

-1.0e+50

—

2.5e+00

—

cases:0.00%

controls:0.17%

—

cases:1.32%

controls:0.11%

—

463

4590

—

448

4536

—

CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]

—

2.5e+00

—

cases:1.50%

controls:0.13%

—

393

3961

Profession-specific psychiatric evaluation
IBZ01 [2001304075]

—

2.5e+00

—

cases:1.50%

controls:0.13%

—

393

3961

Cutaneous abscess, furuncle and carbuncle of buttock
L02.3 [45548181]

—

2.5e+00

—

cases:1.50%

controls:0.13%

—

393

3961

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

3.5e-01

5.1e-01

—

2.5e+00

7.9e-01

6.2e-01

cases:3.67%

controls:2.61%

cases:1.51%

controls:0.91%

—

cases:1.30%

controls:0.11%

cases:1.54%

controls:0.70%

cases:4.76%

controls:2.62%

120

446

4478

456

4556

—

456

4587

447

4509

104

380

3862

buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]

2.5e+00

—

cases:1.30%

controls:0.11%

—

457

4593

—

Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]

1.7e+00

2.5e+00

1.0e+50

—

cases:1.08%

controls:0.20%

cases:1.30%

controls:0.11%

cases:3.24%

controls:0.00%

cases:1.30%

controls:0.00%

—

458

4589

457

4593

448

4598

457

4598

—

Body temperature
8310-5 [3020891]

2.1e+00

2.5e+00

—

1.5e+00

cases:1.08%

controls:0.13%

cases:1.30%

controls:0.11%

—

cases:1.50%

controls:0.35%

458

4592

457

4593

—

393

3952

Bipolar affective disorder, current episode severe depression without psychotic symptoms
F31.4 [45581456]

2.5e+00

—

2.3e+00

—

cases:1.30%

controls:0.11%

—

cases:1.10%

controls:0.11%

—

457

4593

—

449

4536

—

Cathetrisation of vein
TPH04 [2001309597]

9.3e-01

1.0e+00

—

1.0e+50

—

1.6e+00

8.2e-01

cases:4.10%

controls:1.65%

cases:1.94%

controls:0.70%

—

cases:1.08%

controls:0.00%

—

cases:2.64%

controls:0.57%

cases:3.26%

controls:1.46%

444

4522

454

4566

—

458

4598

—

442

4515

386

3908

Cervical dilation and drainage with suction
8511 [2000101376]

2.5e+00

—

cases:1.51%

controls:0.13%

—

456

4592

—

cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]

—

2.4e+00

—

cases:2.01%

controls:0.18%

—

391

3959

Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]

—

2.4e+00

—

cases:2.01%

controls:0.18%

—

391

3959

venlafaxine; oral
N06AX16 [21604745]

1.2e+00

—

7.2e-01

8.0e-01

cases:6.48%

controls:2.04%

cases:3.67%

controls:1.09%

—

cases:2.42%

controls:1.19%

cases:3.51%

controls:1.61%

433

4504

446

4548

—

443

4487

385

3902

Cellulitis of other parts of limb
L03.1 [45586760]

—

2.4e+00

—

cases:2.26%

controls:0.20%

—

390

3958

Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]

1.5e+00

1.7e+00

—

2.4e+00

cases:1.08%

controls:0.24%

cases:1.08%

controls:0.20%

—

cases:2.51%

controls:0.23%

458

4587

458

4589

—

389

3957

Chronic alcohol abuse
P15 [2002000811]

2.4e+00

—

1.9e+00

cases:2.81%

controls:0.26%

—

cases:1.50%

controls:0.23%

450

4586

—

393

3957

clozapine; oral, parenteral
N05AH02 [21604542]

1.4e+00

—

1.4e+00

2.4e+00

cases:1.08%

controls:0.26%

cases:1.08%

controls:0.26%

—

cases:1.10%

controls:0.26%

cases:3.76%

controls:0.35%

458

4586

458

4586

—

449

4529

384

3952

ibuprofen
R02AX02 [1588667]

2.4e-01

4.9e-01

6.3e-01

—

9.3e-01

6.0e-01

3.7e-01

cases:28.51%

controls:23.90%

cases:16.41%

controls:10.77%

cases:1.94%

controls:1.04%

—

cases:3.68%

controls:1.48%

cases:18.50%

controls:11.05%

cases:35.84%

controls:27.86%

132

1099

331

3499

495

387

4103

454

4550

—

445

4524

502

370

4039

143

1105

256

2861

ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]

2.4e-01

4.9e-01

6.3e-01

—

9.3e-01

6.0e-01

3.7e-01

cases:28.51%

controls:23.90%

cases:16.41%

controls:10.77%

cases:1.94%

controls:1.04%

—

cases:3.68%

controls:1.48%

cases:18.50%

controls:11.05%

cases:35.84%

controls:27.86%

132

1099

331

3499

495

387

4103

454

4550

—

445

4524

502

370

4039

143

1105

256

2861

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

1.1e+00

1.2e+00

—

1.0e+50

2.1e+00

9.7e-01

5.4e-01

cases:4.54%

controls:1.52%

cases:3.67%

controls:1.09%

—

cases:1.51%

controls:0.00%

cases:1.08%

controls:0.13%

cases:3.30%

controls:1.28%

cases:4.01%

controls:2.37%

442

4528

446

4548

—

456

4598

457

4586

439

4483

383

3872

ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]

4.2e-01

1.2e+00

—

2.1e+00

1.2e+00

2.6e-01

cases:3.67%

controls:2.44%

cases:2.81%

controls:0.89%

—

cases:1.08%

controls:0.13%

cases:2.86%

controls:0.88%

cases:3.01%

controls:2.34%

112

446

4486

450

4557

—

457

4586

441

4501

387

3873

Boil/carbuncle
S10 [2002000975]

1.4e+00

—

2.3e+00

cases:1.51%

controls:0.37%

—

cases:2.51%

controls:0.25%

456

4581

—

389

3956

Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]

—

2.3e+00

1.7e+00

—

cases:1.32%

controls:0.13%

cases:1.25%

controls:0.23%

—

448

4535

394

3957

moclobemide; oral
N06AG02 [21604727]

1.7e+00

—

2.3e+00

cases:1.51%

controls:0.28%

—

cases:2.01%

controls:0.20%

456

4585

—

391

3958

ursodeoxycholic acid; oral
A05AA02 [21600513]

—

2.3e+00

—

cases:1.10%

controls:0.11%

cases:1.75%

controls:0.18%

—

449

4536

392

3959

Schizophrenia
F20 [45542835]

—

2.3e+00

—

cases:1.75%

controls:0.18%

—

392

3959

Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]

—

2.3e+00

—

cases:1.50%

controls:0.15%

—

393

3960

Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]

—

2.3e+00

—

cases:1.51%

controls:0.15%

—

456

4591

—

Tooth X-ray additional picture
EB1CA [2001301909]

—

2.3e+00

—

cases:1.30%

controls:0.13%

—

457

4592

—

Pneumonia, unspecified
J18.9 [45601123]

1.3e+00

—

1.0e+50

—

1.4e+00

1.0e+00

cases:3.67%

controls:1.07%

cases:1.08%

controls:0.28%

—

cases:1.08%

controls:0.00%

—

cases:1.98%

controls:0.51%

cases:4.01%

controls:1.49%

446

4549

458

4585

—

458

4598

—

445

4518

383

3907

Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]

9.9e-01

1.2e+00

—

6.0e-01

8.5e-01

cases:5.62%

controls:2.15%

cases:2.81%

controls:0.83%

—

cases:1.32%

controls:0.73%

cases:4.26%

controls:1.87%

437

4499

450

4560

—

448

4508

382

3892

Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]

1.0e+00

9.8e-01

—

1.0e+50

—

1.1e+00

1.2e+00

cases:3.67%

controls:1.37%

cases:1.73%

controls:0.65%

—

cases:1.08%

controls:0.00%

—

cases:1.98%

controls:0.64%

cases:4.76%

controls:1.49%

446

4535

455

4568

—

458

4598

—

445

4512

380

3907

Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 [3019539]

1.6e+00

—

2.2e+00

cases:1.30%

controls:0.26%

—

cases:2.01%

controls:0.23%

457

4586

—

391

3957

Procedure duration 50 to 59 minutes
ZXE06 [2001311400]

1.3e+00

—

2.2e+00

cases:1.30%

controls:0.35%

—

cases:2.01%

controls:0.23%

457

4582

—

391

3957

haloperidol; oral, parenteral
N05AD01 [21604516]

—

2.2e+00

—

cases:1.75%

controls:0.20%

—

392

3958

Back syndrome with radiating pain
L86 [2002000705]

2.2e+00

—

cases:1.51%

controls:0.17%

—

456

4590

—

Laceration/cut
S18 [2002000983]

6.2e-01

1.3e+00

—

1.2e-01

9.1e-01

cases:7.99%

controls:4.46%

cases:4.54%

controls:1.33%

—

cases:1.54%

controls:1.37%

cases:8.77%

controls:3.73%

205

426

4393

442

4537

—

447

4479

148

364

3818

Schizoaffective disorder, unspecified
F25.9 [45605490]

—

2.2e+00

—

cases:1.50%

controls:0.18%

—

393

3959

Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 [3028369]

—

2.2e+00

—

cases:1.50%

controls:0.18%

—

393

3959

Procedure duration 90 to 119 minutes
ZXE13 [2001311404]

1.5e+00

-1.0e+50

—

2.2e+00

cases:1.30%

controls:0.30%

cases:0.00%

controls:0.15%

—

cases:1.50%

controls:0.18%

457

4584

463

4591

—

393

3959

Periodontitis pronounced
K05.31 [2000502729]

1.3e+00

2.2e+00

—

1.1e+00

—

cases:1.94%

controls:0.52%

cases:1.30%

controls:0.15%

—

cases:1.10%

controls:0.35%

—

454

4574

457

4591

—

449

4525

—

Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]

2.2e+00

—

cases:1.30%

controls:0.15%

—

457

4591

—

EKG study
11524-6 [3013512]

-1.1e-01

-1.2e-01

2.2e+00

—

8.1e-01

-2.7e-01

cases:3.02%

controls:3.37%

cases:1.51%

controls:1.70%

cases:1.30%

controls:0.15%

—

cases:4.63%

controls:2.11%

cases:3.01%

controls:3.91%

155

449

4443

456

4520

457

4591

—

433

4445

155

387

3811

furosemide; oral, parenteral
C03CA01 [21601518]

1.1e+00

1.0e+00

6.9e-01

—

1.4e+00

9.2e-01

8.0e-01

cases:4.75%

controls:1.61%

cases:3.24%

controls:1.17%

cases:1.08%

controls:0.54%

—

cases:1.52%

controls:0.39%

cases:3.52%

controls:1.43%

cases:4.26%

controls:1.97%

441

4524

448

4544

458

4573

—

455

4574

438

4476

382

3888

diclofenac; oral, parenteral, rectal
M01AB05 [21603945]

4.7e-01

2.5e-01

1.7e+00

—

6.4e-01

3.3e-01

cases:15.12%

controls:9.98%

cases:4.10%

controls:3.22%

cases:1.94%

controls:0.37%

—

cases:5.73%

controls:3.11%

cases:17.04%

controls:12.86%

459

393

4139

148

444

4450

454

4581

—

141

428

4400

510

331

3456

Protein [Mass/volume] in Urine
2888-6 [3037121]

9.7e-01

—

1.8e+00

2.1e+00

cases:1.08%

controls:0.41%

—

cases:1.10%

controls:0.18%

cases:2.26%

controls:0.28%

458

4579

—

449

4533

390

3955

Therapeutic discussion
SPAT1240 [2001700341]

1.1e+00

7.8e-01

—

1.1e+00

1.0e+00

cases:4.97%

controls:1.78%

cases:1.08%

controls:0.50%

—

cases:1.98%

controls:0.64%

cases:3.51%

controls:1.26%

440

4516

458

4575

—

445

4512

385

3916

Alcohol intoxication UNS
F10.09 [2000501676]

2.1e+00

—

2.0e+00

cases:1.73%

controls:0.22%

—

cases:1.25%

controls:0.18%

455

4588

—

394

3959

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

4.8e-01

7.9e-01

2.1e+00

—

1.7e+00

4.9e-01

4.2e-01

cases:4.54%

controls:2.85%

cases:3.24%

controls:1.50%

cases:2.38%

controls:0.30%

—

cases:1.08%

controls:0.20%

cases:2.42%

controls:1.50%

cases:4.76%

controls:3.18%

131

442

4467

448

4529

452

4584

—

457

4583

443

4473

126

380

3840

Social phobias
F40.1 [45595907]

2.1e+00

—

1.3e+00

cases:1.51%

controls:0.20%

—

cases:1.50%

controls:0.40%

456

4589

—

393

3950

Fall on and from stairs and steps
W10 [45756250]

2.1e+00

—

cases:1.51%

controls:0.20%

—

456

4589

—

Addiction caused by alcohol UNS
F10.29 [2000501684]

2.1e+00

—

cases:1.51%

controls:0.20%

—

456

4589

—

lithium; oral
N05AN01 [21604556]

2.0e+00

—

1.7e+00

1.5e+00

cases:1.94%

controls:0.26%

—

cases:1.32%

controls:0.24%

cases:1.50%

controls:0.33%

454

4586

—

448

4530

393

3953

Monitoring of emergency patient
SPAT1104 [2001700205]

—

2.0e+00

—

cases:1.50%

controls:0.20%

—

393

3958

Gas panel - Central venous blood
97535-9 [1616796]

2.0e+00

—

cases:1.30%

controls:0.17%

—

457

4590

—

Hospital outpatient
ZY010 [2001311599]

1.1e+00

—

2.0e+00

cases:1.73%

controls:0.59%

—

cases:2.76%

controls:0.38%

455

4571

—

388

3951

escitalopram; oral
N06AB10 [21604718]

9.1e-01

8.3e-01

—

1.1e+00

7.5e-01

cases:5.62%

controls:2.35%

cases:3.24%

controls:1.44%

—

cases:1.08%

controls:0.37%

cases:3.96%

controls:1.37%

cases:6.27%

controls:3.05%

108

437

4490

448

4532

—

457

4575

436

4479

121

374

3845

Low back pain
M54.5 [45553207]

8.7e-01

1.1e+00

—

6.7e-01

3.1e-01

cases:7.56%

controls:3.33%

cases:3.67%

controls:1.22%

—

cases:3.08%

controls:1.61%

cases:5.26%

controls:3.93%

153

428

4445

446

4542

—

440

4468

156

378

3810

pH of Blood
11558-4 [3010421]

2.0e+00

—

cases:1.73%

controls:0.24%

—

455

4587

—

sildenafil; oral
G04BE03 [21602648]

8.7e-01

1.1e+00

—

8.5e-01

5.0e-01

cases:4.32%

controls:1.85%

cases:3.02%

controls:1.02%

—

cases:2.64%

controls:1.15%

cases:3.51%

controls:2.17%

443

4513

449

4551

—

442

4489

385

3880

Bacteria identified in Isolate by Culture
43409-2 [3042936]

9.3e-01

1.1e+00

—

1.5e+00

1.0e+00

cases:3.67%

controls:1.48%

cases:1.08%

controls:0.35%

—

cases:1.32%

controls:0.31%

cases:3.76%

controls:1.36%

446

4530

458

4582

—

448

4527

384

3912

salbutamol; inhalant
R03AC02 [21603256]

6.0e-01

4.4e-01

—

6.9e-01

cases:14.69%

controls:8.63%

cases:6.48%

controls:4.26%

—

cases:7.49%

controls:3.92%

cases:16.29%

controls:8.93%

397

395

4201

196

433

4402

—

178

420

4363

354

334

3612

Infiltration anesthesia
WX110 [2001310767]

2.8e-01

6.2e-01

1.4e+00

—

6.5e-01

8.3e-01

5.2e-01

cases:17.71%

controls:13.94%

cases:9.29%

controls:5.20%

cases:1.73%

controls:0.43%

—

cases:1.08%

controls:0.57%

cases:10.13%

controls:4.69%

cases:20.05%

controls:13.01%

641

381

3957

239

420

4359

455

4578

—

457

4566

213

408

4328

516

319

3450

Home Visit
OMOP4822459 [581476]

2.3e-01

4.3e-01

1.1e+00

—

1.5e+00

1.1e+00

8.4e-01

cases:3.89%

controls:3.11%

cases:2.16%

controls:1.41%

cases:1.30%

controls:0.46%

—

cases:1.95%

controls:0.46%

cases:4.41%

controls:1.48%

cases:6.77%

controls:3.03%

143

445

4455

453

4533

457

4577

—

453

4571

434

4474

120

372

3846

Telehealth
OMOP5556618 [722455]

3.0e-01

5.9e-01

1.4e+00

—

1.2e+00

5.1e-01

4.2e-01

cases:19.65%

controls:15.29%

cases:9.29%

controls:5.35%

cases:3.02%

controls:0.78%

—

cases:2.60%

controls:0.81%

cases:7.71%

controls:4.78%

cases:15.29%

controls:10.62%

703

372

3895

246

420

4352

449

4562

—

450

4555

217

419

4324

421

338

3545

trazodone; oral
N06AX05 [21604734]

—

2.0e+00

—

cases:1.75%

controls:0.25%

—

392

3956

Oxygen [Partial pressure] in Blood
11556-8 [3027315]

2.0e+00

—

cases:1.51%

controls:0.22%

—

456

4588

—

Base excess in Blood by calculation
11555-0 [3012501]

2.0e+00

—

cases:1.51%

controls:0.22%

—

456

4588

—

Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]

2.0e+00

—

cases:1.51%

controls:0.22%

—

456

4588

—

Other and unspecified convulsions
R56.8 [45602033]

2.0e+00

—

cases:1.51%

controls:0.22%

—

456

4588

—

Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]

1.3e+00

—

1.9e+00

cases:1.51%

controls:0.41%

—

cases:2.76%

controls:0.40%

456

4579

—

388

3950

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
6350C [2000404981]

1.9e+00

—

cases:2.38%

controls:0.35%

—

452

4582

—

Extraction of tooth
EBA00 [2001301923]

5.4e-01

8.3e-01

—

1.3e+00

6.6e-01

cases:6.48%

controls:3.87%

cases:2.81%

controls:1.24%

—

cases:3.96%

controls:1.15%

cases:8.27%

controls:4.44%

178

433

4420

450

4541

—

436

4489

176

366

3790

doxepin; oral, parenteral
N06AA12 [21604699]

1.9e+00

—

1.4e+00

cases:3.02%

controls:0.46%

—

cases:2.26%

controls:0.55%

449

4577

—

390

3944

Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]

1.0e+00

1.9e+00

—

1.4e+00

7.3e-01

cases:2.16%

controls:0.80%

cases:1.73%

controls:0.26%

—

cases:1.54%

controls:0.37%

cases:1.50%

controls:0.73%

453

4561

455

4586

—

447

4524

393

3937

Procedure duration 60 to 89 minutes
ZXE11 [2001311402]

1.2e+00

—

1.9e+00

cases:2.16%

controls:0.65%

—

cases:2.26%

controls:0.35%

453

4568

—

390

3952

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

113

63.26

200.24

2.3

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

25.93

123.98

1.2

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

118

15.31

121.99

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

113

15.59

118.78

1.2

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

134

155

11.46

111.81

1.3

1.2

71.54

87.33

titre

0.28

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

183

373

7.18

92.99

3.4

2.8

0.18

0.23

g/l

9.92

170

351

(3028707) Methadone [Presence] in Urine by Screen method

106

126

10.42

85.65

10.7

1.7

—

(3011288) Drugs identified in Urine by Screen method Nominal

126

201

8.05

79.76

15.5

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

262

897

5.05

71.45

2.2

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

369

1690

5.57

68.56

8.1

5.3

35.00

36.59

g/l

4.96

359

1618

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

+∞

66.14

1.4

0.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

216

682

4.83

64.04

2.2

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

119

223

6.70

63.94

10.2

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

346

1569

4.95

63.31

7.5

3.4

95.41

31.37

u/l

5.88

337

1494

(3016879) Cocaine [Presence] in Urine

128

265

6.16

61.98

10.3

1.5

—

(3027008) Opiates [Presence] in Urine

131

283

5.92

60.52

10.1

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

411

2182

6.06

60.09

12.4

6.6

17.82

11.34

umol/l

4.95

401

2087

(3000764) Benzodiazepines [Presence] in Urine

130

281

5.91

59.99

10.3

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

9.30

59.24

3.6

4.6

38.87

36.93

umol/l

0.21

(3028300) Cannabinoids [Presence] in Urine

130

285

5.82

59.01

10.3

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

264

1040

4.27

56.87

8.4

4.1

85.98

92.80

4.19

258

1025

(3027944) Amphetamines [Presence] in Urine

126

282

5.64

55.69

8.7

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

119

260

5.70

53.90

2.9

1.7

0.30

0.34

mg/l

0.39

120

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

13.10

51.34

1.2

1.0

—

(4198724) Urine methamphetamine measurement

17.34

50.93

3.7

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

101

8.16

50.06

4.0

7.8

510.40

476.53

iu/ml

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

130

7.03

47.54

1.6

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

162

510

4.23

46.19

5.0

2.8

28.89

8.42

umol/l

4.52

140

457

(3023368) Bacteria identified in Blood by Culture

245

1038

3.68

44.97

7.1

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

254

1109

3.63

44.35

2.9

2.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

149

454

4.26

44.22

2.1

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

194

738

3.67

41.43

3.2

1.9

1.62

1.41

4.99

175

662

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

117

6.80

41.33

1.3

1.2

206.11

242.14

u/ml

0.40

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

120

6.40

37.99

1.1

1.5

—

(3012544) pH of Venous blood

128

387

4.11

37.87

5.0

3.7

7.38

0.31

225

(3037522) Nuclear Ab [Titer] in Serum

179

691

3.48

36.69

1.5

1.4

227.69

429.37

titre

3.00

143

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

188

5.17

36.32

1.8

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

132

425

3.87

35.54

4.1

2.6

26.68

142.51

u/l

0.52

116

364

(3002032) Base excess in Venous blood by calculation

122

374

4.00

35.21

5.0

3.7

1.10

1.81

mmol/l

0.98

105

327

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

14.80

35.09

2.8

2.5

89.50

85.73

umol/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

153

559

3.51

33.87

2.6

2.7

21.54

24.30

1.78

148

531

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

8.84

33.85

1.3

—

(3032080) INR in Blood by Coagulation assay

309

1706

3.14

33.58

12.9

9.8

1.17

1.16

inr

0.25

258

1402

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

266

1353

3.07

33.44

4.5

2.7

53.44

62.56

u/l

1.53

248

1279

(3048929) Epstein Barr virus Ab [Presence] in Serum

202

4.80

33.23

1.4

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

168

661

3.33

32.89

2.6

2.7

13.21

14.15

umol/l

0.84

163

620

(42870588) Differential panel, method unspecified - Blood

273

1422

3.04

32.65

8.7

6.2

—

(3001604) Monocytes [#/volume] in Blood

364

2238

3.33

32.18

10.3

6.6

0.57

0.56

e9/l

0.22

324

1943

(3006315) Basophils [#/volume] in Blood

364

2246

3.31

31.81

10.4

6.6

0.04

e9/l

0.46

323

1948

(3004789) Transferrin [Mass/volume] in Serum or Plasma

158

614

3.30

31.38

2.5

2.7

2.46

2.33

g/l

1.73

153

572

(3013115) Eosinophils [#/volume] in Blood

370

2324

3.30

30.96

11.4

6.9

0.18

0.19

e9/l

0.74

332

2052

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

111

5.90

30.72

1.1

1.4

148.08

162.46

au/ml

0.35

(3019198) Lymphocytes [#/volume] in Blood

367

2300

3.26

30.71

10.4

6.6

1.97

1.98

e9/l

0.03

332

2046

(3019069) Monocytes/Leukocytes in Blood

342

2064

3.10

30.52

9.7

6.6

8.49

8.69

0.76

331

1967

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

324

1923

2.96

29.34

12.4

8.0

1.20

1.21

mmol/l

3.58

294

1689

(3022096) Basophils/Leukocytes in Blood

338

2054

3.01

29.26

10.0

6.5

0.71

0.70

0.04

327

1944

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

125

438

3.48

29.12

2.1

1.9

—

(3006504) Eosinophils/Leukocytes in Blood

338

2060

2.99

28.98

9.8

6.5

2.63

2.86

1.26

327

1961

(3042936) Bacteria identified in Isolate by Culture

148

578

3.22

28.87

2.5

2.2

—

(3002030) Lymphocytes/Leukocytes in Blood

345

2136

3.00

28.54

9.8

6.4

30.43

28.46

2.13

334

2054

(3018418) pH of Serum or Plasma

232

1172

2.83

28.30

5.3

4.2

7.40

0.13

175

835

(3018010) Neutrophils/Leukocytes in Blood

341

2108

2.96

28.10

9.7

6.4

54.84

56.85

2.23

332

2038

(3013650) Neutrophils [#/volume] in Blood by Automated count

379

2492

3.18

27.70

16.7

9.9

3.91

4.06

e9/l

0.71

343

2185

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

126

459

3.34

27.44

2.0

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

152

619

3.10

27.43

2.0

1.9

—

(40758558) Short blood count panel - Blood

241

1266

2.75

26.90

8.7

6.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

137

534

3.16

26.57

15.2

9.0

104.64

104.09

mmol/l

0.65

137

534

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

294

1719

2.73

26.33

11.9

7.3

1.20

1.21

mmol/l

2.77

283

1604

(3009508) Creatinine [Moles/volume] in Urine

254

1390

2.69

25.85

8.7

3.3

7.37

8.31

mmol/l

2.38

229

1192

(3021589) Normoblasts [#/volume] in Blood

320

1973

2.74

25.43

16.7

10.1

0.00

e9/l

0.46

272

1610

(3002582) Erythrocytes [#/volume] in Urine

241

1314

2.62

24.31

3.9

3.2

17.21

93.69

e6/l

0.88

189

983

(3013826) Glucose [Moles/volume] in Serum or Plasma

360

2407

2.79

23.47

10.5

5.5

6.66

6.59

mmol/l

0.22

349

2267

(3003458) Phosphate [Moles/volume] in Serum or Plasma

132

539

2.97

23.29

8.2

6.7

1.04

1.02

mmol/l

0.49

127

506

(3031040) Bacteria [#/volume] in Urine by Automated count

382

2664

2.86

22.35

5.7

4.1

38.40

259.92

e6/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

201

1040

2.56

22.14

1.7

1.4

2.62

2.39

g/l

0.87

148

681

(3030467) Casts [#/volume] in Urine by Automated count

212

1138

2.50

21.44

3.8

3.0

0.88

0.29

e6/l

0.91

163

809

(36304419) Bacteria [Presence] in Urine

207

1099

2.51

21.44

3.6

2.9

—

0.00

estimate

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

101

375

3.12

20.88

4.6

2.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

121

500

2.88

20.65

2.2

1.6

—

(3018095) Leukocytes [#/volume] in Urine

257

1537

2.39

20.08

4.9

3.8

96.50

99.17

e6/l

0.02

194

1053

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

149

697

2.62

19.90

2.9

2.8

1.37

0.83

e6/l

0.91

345

(3012095) Magnesium [Moles/volume] in Serum or Plasma

145

680

2.60

19.17

4.9

3.7

0.80

0.82

mmol/l

1.29

139

657

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

7.10

18.88

6.4

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

189

1010

2.40

18.79

2.7

2.2

2.58

2.73

mg/l

0.45

168

881

(3026008) Bacteria identified in Urine by Culture

194

1049

2.39

18.78

3.9

2.8

—

(3000991) Gas panel - Venous blood

342

3.03

18.28

18.2

11.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

138

647

2.57

18.14

3.0

2.9

2.47

2.28

e6/l

0.10

296

(3000850) Epithelial cells [#/volume] in Urine

172

893

2.41

18.13

3.2

2.6

11.10

5.30

e6/l

2.41

162

810

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

214

1245

2.26

17.09

2.8

2.2

359.89

201.55

u/l

1.07

209

1193

(3015736) pH of Urine

283

1869

2.19

16.20

5.3

3.2

6.35

6.17

1.84

158

1099

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

423

3317

2.83

16.10

8.2

3.3

87.47

45.62

u/l

9.04

412

3192

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

222

3.27

15.91

5.1

2.7

0.61

0.03

222

(3003396) Base excess in Arterial blood by calculation

420

2.66

15.25

16.8

11.9

1.72

0.85

mmol/l

1.49

355

(3026782) Osmolality of Urine

148

769

2.32

15.17

3.7

2.7

514.24

538.56

mosm/kgh2o

0.61

138

667

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

204

3.27

14.82

1.7

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

407

3180

2.53

14.72

5.1

4.1

12.85

9.84

mm/h

3.81

385

2997

(3019977) pH of Arterial blood

422

2.58

14.12

17.3

11.9

7.40

7.41

0.88

236

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

210

3.17

14.11

1.5

1.4

148.35

246.37

miu/ml

1.23

111

(3021601) Nitrite [Presence] in Urine by Test strip

321

2296

2.12

14.11

4.5

3.4

0.00

estimate

0.50

451

(3009261) Glucose [Presence] in Urine by Test strip

325

2336

2.13

14.09

4.5

3.5

0.00

0.03

estimate

1.33

421

(3021960) Folate [Moles/volume] in Serum or Plasma

184

1074

2.13

13.95

1.9

1.6

17.66

20.70

nmol/l

2.50

173

931

(3035350) Ketones [Presence] in Urine by Test strip

322

2317

2.10

13.78

4.5

3.5

0.00

6.72

estimate

0.80

451

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

156

3.45

13.54

1.3

1.4

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

18.88

13.47

1.4

1.1

—

(3019150) Specific gravity of Urine by Refractometry

177

1036

2.10

13.18

6.4

3.3

1.02

kg/l

1.14

119

674

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

255

1708

2.01

13.04

2.3

2.0

95.51

97.59

pmol/l

0.32

154

921

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

4.32

12.97

3.8

2.9

0.28

0.34

iu/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

4.43

12.64

5.7

7.5

331.38

373.54

umol/l

0.73

(3037467) Urinalysis macro (dipstick) panel - Urine

374

2905

2.15

12.32

5.5

4.1

—

3.17

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

5.69

12.22

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

4.40

12.16

3.7

2.4

1320.00

2306.67

titre

—

(3023511) Choriogonadotropin [Units/volume] in Urine

121

3.60

12.06

2.0

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

197

3.01

11.86

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

206

1319

1.96

11.63

4.3

3.4

2.35

mmol/l

0.31

193

1217

(3027945) Reticulocytes/Erythrocytes in Blood

401

2.42

11.44

2.7

3.3

1.97

1.85

0.31

369

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

167

1001

2.01

11.35

3.3

2.2

—

(3044640) Blood type and Crossmatch panel - Blood

207

1341

1.93

11.18

3.6

2.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

471

4112

3.68

11.12

25.5

12.6

90.41

87.95

ml/min/173m2

1.57

452

3770

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

4.28

11.02

1.8

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

483

4311

5.00

10.49

33.3

15.5

3.95

3.96

mmol/l

0.03

476

4218

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

126

701

2.07

10.40

3.1

2.7

2.43

mmol/l

0.03

117

632

(3021440) Promyelocytes/Leukocytes in Blood

338

2.44

10.32

6.4

4.6

0.04

0.15

1.21

(3019550) Sodium [Moles/volume] in Serum or Plasma

482

4303

4.74

10.31

33.5

15.4

139.17

139.69

mmol/l

5.07

476

4225

(40760892) CBC W Ordered Manual Differential panel - Blood

175

1100

1.91

10.14

6.8

5.0

—

(3017181) Myelocytes/Leukocytes in Blood

361

2.38

10.12

6.2

4.5

0.45

0.96

1.87

106

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

100

3.58

10.05

1.8

1.6

—

(40768441) Liver Pathology biopsy report

7.62

9.80

1.6

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

430

2.24

9.67

3.0

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

3.61

9.63

1.7

2.0

0.93

0.80

g/l

0.24

(3025159) Blasts/Leukocytes in Blood

349

2.35

9.59

6.7

5.0

0.07

0.10

0.14

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

357

2.33

9.51

2.9

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

131

761

1.98

9.50

4.2

3.7

111.99

456.59

ng/l

1.93

532

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

280

2.48

9.37

3.9

4.3

83.72

86.67

ng/l

0.11

255

(3001122) Ferritin [Mass/volume] in Serum or Plasma

291

2185

1.80

9.18

3.8

3.1

168.41

111.66

ug/l

1.90

279

2083

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

269

1976

1.79

9.12

3.6

2.7

—

estimate

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

280

2.43

8.91

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

186

1232

1.81

8.90

4.6

3.6

0.00

0.01

estimate

0.88

431

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

479

4318

3.87

8.81

29.0

13.7

22.49

22.36

mg/l

0.04

438

3487

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

124

727

1.94

8.67

3.0

2.1

—

(3024928) Oxygen saturation in Venous blood

106

3.26

8.54

6.1

3.3

62.84

63.62

0.07

106

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

160

1024

1.83

8.50

2.0

1.8

1.29

1.18

mg/l

0.17

132

780

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

112

3.18

8.45

1.5

1.6

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

321

2.30

8.39

3.4

2.5

70.54

72.26

ml/min/173m2

0.09

149

(3002179) Metamyelocytes/Leukocytes in Blood

350

2.24

8.28

5.5

4.5

0.52

0.60

0.14

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

133

2.92

7.93

3.4

2.6

3.73

3.58

g/l

0.18

128

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

162

2.74

7.92

1.7

2.2

1.62

1.41

g/l

0.59

147

(3044889) 12 lead EKG panel

362

2964

1.81

7.90

4.5

3.6

—

14431.00

—

(3052851) Hemolysis interference index of Serum or Plasma

106

3.16

7.88

4.5

3.5

2.11

1.97

index

0.05

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

172

1150

1.76

7.76

1.4

1.3

1.34

1.99

u/ml

0.50

327

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

450

3976

2.37

7.73

6.3

5.2

1.72

1.83

mu/l

1.43

433

3752

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

398

3365

1.91

7.71

4.9

4.3

14.63

14.52

pmol/l

0.42

374

3134

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

129

793

1.85

7.70

3.3

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

255

1909

1.69

7.55

3.0

2.5

70.47

74.05

nmol/l

1.20

243

1756

(21494815) CD4 cells/Lymphocytes in Specimen

4.52

7.48

3.6

1.9

32.58

40.74

1.66

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

104

3.11

7.48

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

7.83

7.44

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

111

3.01

7.31

1.0

1.3

26.80

14.56

e6/l

0.26

(36660697) Celiac disease serology panel - Serum

403

2.05

6.98

1.2

—

(3011648) Oxygen content in Venous blood

4.08

6.95

2.1

1.6

10.05

11.34

0.55

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

3.89

6.87

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

563

1.90

6.86

1.6

1.7

1204.82

1157.94

nmol/l

0.18

436

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.36

6.64

1.8

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

8.31

6.36

2.8

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

5.64

6.35

16.6

9.2

48.70

48.45

u/ml

—

(3036180) Methadone [Presence] in Urine

+∞

6.26

2.0

0.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

3.22

6.25

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

5.15

6.24

3.7

2.7

33.49

42.74

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

110

2.84

6.23

2.2

2.4

—

(3012516) Albumin [Mass/volume] in Urine

174

1225

1.65

6.22

4.2

3.5

80.18

63.32

mg/l

0.30

131

796

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.98

6.14

1.8

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

153

2.53

6.10

4.9

3.2

107.31

1398.69

u/ml

0.79

133

(1761868) Lipid panel - Serum or Plasma

149

2060

0.61

6.06

3.6

2.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

176

1250

1.63

6.05

5.0

4.2

14.96

10.90

mg/mmol

0.45

127

783

(3023520) Reticulocytes [#/volume] in Blood

293

2.11

6.04

1.6

3.4

79.86

74.39

e9/l

0.47

212

(40768797) Stomach Pathology biopsy report

571

1.82

5.98

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

219

2.27

5.97

2.6

2.3

—

(3000494) Fungus identified in Specimen by Culture

557

1.82

5.92

1.5

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

145

989

1.66

5.81

3.0

3.4

995.10

844.50

ng/l

0.26

130

812

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

233

1791

1.57

5.63

4.8

3.2

0.00

0.02

estimate

1.15

388

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

204

1526

1.57

5.53

4.0

3.2

43.63

76.18

ng/l

0.33

131

961

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

340

1.94

5.16

4.3

4.5

12.72

20.18

ug/l

0.19

278

(3026493) Urate [Moles/volume] in Serum or Plasma

153

1092

1.58

4.98

3.2

2.7

334.28

340.61

umol/l

0.30

139

986

(3044290) Cell count panel - Cerebral spinal fluid

100

2.69

4.97

1.1

1.4

—

(3037121) Protein [Mass/volume] in Urine

144

2.38

4.89

4.3

4.5

155.74

324.17

mg/l

1.03

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

3.24

4.81

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.59

4.79

2.3

3.4

0.63

0.62

mmol/l

0.05

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

3.48

4.78

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

3.10

4.72

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

3.10

4.72

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

3.10

4.72

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

3.10

4.72

1.7

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

161

2.26

4.61

1.7

1.5

1.23

1.20

g/l

0.15

152

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

127

884

1.59

4.56

1.4

1.3

23.73

27.52

iu/ml

0.35

271

(3019832) Treponema pallidum Ab [Presence] in Serum

634

1.66

4.48

2.3

1.9

—

(3042631) Mycobacterium sp identified in Specimen

4.15

4.44

1.7

3.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

483

4567

2.91

4.38

35.0

16.9

75.27

75.62

umol/l

0.09

483

4521

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2.95

4.38

1.5

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

278

1.93

4.33

1.9

2.3

5.66

8.97

ug/l

1.13

255

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

159

2.22

4.32

2.5

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

3.11

4.28

2.4

2.9

4.38

0.96

0.64

(3023420) DNA double strand Ab [Units/volume] in Serum

208

2.06

4.25

1.6

2.1

5.30

5.28

iu/ml

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.81

4.23

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.81

4.23

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2.70

4.11

1.8

1.3

—

(3012501) Base excess in Blood by calculation

2.82

4.06

3.5

2.7

2.28

2.43

mmol/l

—

(3017509) Phencyclidine [Presence] in Urine

10.12

4.02

7.9

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

10.12

4.02

1.7

3.7

36.63

10.43

mg/mmol

—

(1616796) Gas panel - Central venous blood

2.70

3.94

3.1

2.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

512

0.44

3.90

2.0

1.7

3.39

3.52

mmol/l

0.29

374

(3035715) Granulocytes [#/volume] in Blood

2.74

3.87

2.1

3.5

4.01

4.17

e9/l

0.13

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

223

1.96

3.86

3.5

2.3

119.25

5028.35

u/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

3.06

3.72

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

5.71

3.67

4.1

5.7

15.07

17.58

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

130

2.22

3.65

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

2.71

3.60

1.3

1.6

—

(21494755) Public health laboratory ask at order entry panel

623

0.51

3.58

1.3

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

2.43

3.53

2.2

3.2

57.11

58.57

0.22

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.23

3.51

1.8

2.0

17.11

17.76

umol/l

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

2.36

3.48

1.3

1.5

6942.47

7006.12

e6/l

0.01

(3021387) Prolactin [Units/volume] in Serum or Plasma

235

1.86

3.33

1.7

1.6

422.29

285.69

mu/l

1.21

217

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

4.41

3.32

1.1

1.6

—

(3019060) Gas panel - Arterial blood

201

1.91

3.21

8.5

7.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

3.85

3.20

1.7

3.3

3060.27

1327.07

0.55

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

674

0.56

3.18

1.8

2.0

3.86

3.55

ratio

0.55

536

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.78

3.18

1.2

1.1

—

(40768443) Skin Pathology biopsy report

168

1.97

3.07

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

5.90

3.03

2.4

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

2.80

3.01

1.0

1.4

—

(3009343) pH of Capillary blood

244

1.79

2.98

2.7

3.1

7.42

7.41

0.80

206

(3036481) Cortisol [Moles/volume] in Serum or Plasma

459

1.58

2.96

3.2

2.2

403.79

383.58

nmol/l

0.25

436

(3035637) Corticotropin [Mass/volume] in Plasma

2.88

2.94

3.2

1.3

84.21

23.38

ng/l

0.50

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

440

4113

1.60

2.88

5.8

4.5

6.24

5.86

mmol/l

2.67

418

3864

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

223

1860

1.36

2.87

2.2

1.9

1.48

1.44

mmol/l

0.30

202

1628

(3015171) Extractable nuclear Ab [Units/volume] in Serum

203

1.83

2.82

1.2

—

2.37

—

(3012441) Differential panel - Pleural fluid

3.62

2.79

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

3.28

2.74

2.6

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

2.75

2.73

1.6

1.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.05

2.73

2.0

3.6

5.14

5.06

ug/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

351

3155

1.38

2.73

3.7

3.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.05

2.71

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.05

2.71

1.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.06

2.70

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

6.06

2.70

3.0

1.2

—

(40761511) CBC panel - Blood by Automated count

472

4507

1.91

2.69

23.0

11.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.26

2.69

1.0

1.7

—

(40761536) Microorganisms panel - Urine sediment

339

1.63

2.68

4.9

3.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.70

2.64

1.3

1.2

1.13

1.53

nmol/l

0.64

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2.30

2.63

1.1

1.4

—

216.67

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.97

2.63

1.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.34

2.60

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.05

2.57

1.1

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.05

2.57

1.1

1.8

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.77

2.56

1.0

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

426

1.55

2.53

9.8

6.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

109

824

1.41

2.51

1.3

1.33

9.52

u/ml

4.47

335

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2.24

2.50

2.4

1.9

120.25

131.57

g/l

1.49

(40768806) Pleura Pathology biopsy report

3.51

2.49

1.6

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.85

2.47

2.5

2.9

1.63

1.10

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2.13

2.46

2.6

3.0

1.70

2.46

ratio

0.33

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

2.08

2.45

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

2.08

2.45

1.1

2.0

0.80

0.83

nmol/l

0.09

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.94

2.43

1.0

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.39

2.41

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

209

1.73

2.30

2.5

3.1

1.47

1.32

mmol/l

0.13

154

(3000093) Morphology [Interpretation] in Blood Narrative

2.98

2.29

1.0

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.79

2.28

1.0

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.52

2.28

4.5

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.66

2.27

2.5

6.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.93

2.26

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.37

2.23

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.89

2.22

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.89

2.22

1.1

1.6

—

(3013727) Leukocytes other/Leukocytes in Blood

5.60

2.22

3.8

3.4

44.20

48.61

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

204

1.72

2.21

1.6

1.4

11.69

8.34

u/l

0.54

168

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

429

4036

1.45

2.20

7.7

5.6

40.01

38.57

mmol/mol

1.83

414

3855

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2.11

2.19

1.4

1.8

—

(37208534) Antinuclear antibody arbitrary concentration in serum

3.72

2.15

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.32

2.15

3.7

2.1

—

(4281824) Cell count and differential, peritoneal fluid

2.81

2.15

1.6

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

2.24

2.13

3.7

4.1

12.87

391.57

u/ml

0.54

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.48

2.12

1.0

1.2

—

(3045788) Cell count panel - Pleural fluid

3.23

2.10

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

3.23

2.10

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

2.21

2.06

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.36

2.06

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.04

2.04

1.2

1.1

14.12

8.54

ug/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.43

2.04

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.53

2.02

1.5

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.11

2.02

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

2.84

2.01

1.0

1.4

1.81

mmol/l

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.18

2.00

1.3

1.4

629.99

322.26

mu/l

—

(3023410) Appearance of Cerebral spinal fluid

2.32

1.99

1.2

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.37

1.97

4.7

4.9

7.79

8.85

mmol/l

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

102

794

1.36

1.96

1.8

1.6

73404695.02

23960260.46

pmol/l

0.29

697

(3018333) Ribosomal P Ab [Presence] in Serum

2.60

1.95

1.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

2.76

1.94

2.9

3.0

—

(3002619) Bacteria identified in Specimen by Culture

4.20

1.82

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

1.85

1.81

1.1

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.60

1.81

1.8

2.6

33.00

33.43

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

232

0.46

1.81

1.0

1.1

1.48

1.54

g/l

0.31

232

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.07

1.80

2.3

4.0

1545.86

548.48

u/ml

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.07

1.80

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

128

1044

1.30

1.79

1.7

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.37

1.79

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

2.12

1.77

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.36

1.75

1.5

1.7

—

(3042733) HLA Ab [Presence] in Serum

3.36

1.75

2.7

4.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

514

1.40

1.74

2.5

2.4

11.03

13.56

nmol/l

1.79

486

(4034850) Laboratory test

133

1.76

1.73

18.6

9.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.87

1.72

1.2

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

2.53

1.67

5.0

3.9

2.75

3.43

nmol/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

112

1.82

1.67

1.3

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

127

1.77

1.67

1.4

1.3

227.06

305.22

ug/g

1.28

(3021788) Differential panel - Synovial fluid

2.13

1.67

1.5

1.4

—

(3024263) Appearance of Synovial fluid

3.18

1.66

1.0

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.96

1.66

1.5

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.60

1.62

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

306

1.48

1.61

1.2

1.3

—

39.52

—

(3003694) ABO and Rh group [Type] in Blood

157

1331

1.26

1.60

1.5

—

(4195642) Thrombophilia screening test

2.03

1.60

1.1

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

2.45

1.54

1.1

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

2.45

1.54

1.1

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

2.45

1.54

1.1

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.36

1.52

1.6

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.36

1.52

1.0

1.2

1488.20

66.80

nmol/24h

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

310

1.46

1.52

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.88

1.51

1.3

1.1

122.67

194.60

mmol/24h

—

(3017732) Neutrophils [#/volume] in Blood

548

1.34

1.46

4.1

3.0

4.41

6.03

e9/l

0.77

498

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.15

1.44

1.6

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.33

1.43

2.1

4.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.88

1.41

1.1

1.2

4.14

5.00

u/ml

—

(3051651) Icteric interference index of Serum or Plasma

2.43

1.39

8.3

4.5

0.71

0.97

index

—

(4062490) Immunoglobulin typing, IgG

2.10

1.39

1.0

1.4

—

(3045414) Leukocytes [Presence] in Urine

370

1.39

1.34

1.7

2.2

0.00

0.03

estimate

0.49

(3041096) Erythrocytes [Presence] in Urine by Automated

156

1347

1.23

1.33

4.5

2.8

0.00

0.01

estimate

0.99

372

(4035726) Immunohistochemistry procedure

328

1.41

1.32

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

2.11

1.31

1.2

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.52

1.30

1.3

1.7

56.87

9.44

nmol/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.37

1.29

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

135

0.44

1.29

1.2

1.1

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

486

4764

1.84

1.28

44.6

20.7

90.70

90.57

0.25

486

4732

(21494890) Protein electrophoresis panel - 24 hour Urine

2.31

1.27

1.5

2.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.84

1.26

1.0

1.1

—

(3017704) Immunofixation for Urine

2.42

1.24

1.8

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

238

0.58

1.23

1.8

1.1

0.91

0.89

g/l

0.09

238

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.99

1.23

1.1

1.3

—

72.54

—

(3035941) MCH [Entitic mass]

486

4767

1.81

1.22

44.6

20.6

30.27

30.30

0.15

486

4735

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

486

4767

1.81

1.22

47.0

21.3

39.87

42.15

1.71

486

4730

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.06

1.22

1.2

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.82

1.22

3.8

2.9

10.69

7.22

pmol/l

0.48

(40768446) Kidney Pathology biopsy report

2.65

1.22

1.0

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.65

1.22

1.4

1.8

2.55

0.92

ug/l

—

(3000963) Hemoglobin [Mass/volume] in Blood

486

4769

1.79

1.19

45.1

20.9

133.61

138.45

g/l

9.75

486

4735

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.32

1.19

1.2

13.17

35.72

u/l

—

(3023419) Bacteria identified in Sputum by Culture

2.02

1.17

1.5

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.51

1.15

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

2.02

1.12

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.80

1.12

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

138

0.50

1.11

1.3

1.6

—

(3025941) Bacteria identified in Stool by Culture

270

1.40

1.10

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

277

0.64

1.08

1.3

1.6

1011.22

950.71

mu/l

0.11

231

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.14

1.06

3.3

1.9

—

(3035285) Chloride [Moles/volume] in Venous blood

1.93

1.02

3.4

2.6

107.44

105.81

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

1.93

1.02

3.4

2.6

4.08

4.01

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.93

1.02

3.4

2.6

1.22

1.18

mmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

139

1.53

1.02

1.5

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.01

1.00

1.9

1.2

87.00

108.09

pmol/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.16

0.92

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.16

0.92

1.0

1.1

438.50

197.53

iu/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

449

4368

1.28

0.90

6.3

5.2

2.67

2.81

mmol/l

3.08

427

4157

(3049717) Cytology report of Urine Cyto stain

128

1.50

0.87

3.1

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

138

1.47

0.83

1.6

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

139

1.46

0.80

1.5

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.51

0.78

1.2

1.5

42.37

53.96

ug/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

140

1.45

0.78

1.6

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

1.77

0.76

1.8

1.6

13.38

10.95

umol/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1.58

0.75

1.2

2.88

4.69

u/ml

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

133

1.45

0.74

1.4

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

659

1.20

0.73

2.4

2.5

84.89

100.82

ug/g

0.37

535

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

424

4121

1.19

0.71

4.7

4.0

1.41

1.31

mmol/l

1.61

405

3895

(3023323) Follitropin [Units/volume] in Serum or Plasma

302

1.28

0.70

1.3

1.4

24.69

22.18

iu/l

0.18

257

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

322

1.26

0.67

1.6

1.5

—

(3022313) Gas panel - Capillary blood

171

1.36

0.67

2.2

3.3

—

(3002256) Pathology report gross observation

527

1.20

0.64

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.73

0.64

1.0

—

1.09

—

(3044927) Protein electrophoresis panel - Urine

1.73

0.64

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.73

0.64

1.2

1.0

1958.20

1638.83

miu/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

443

4332

1.20

0.62

5.7

4.8

4.49

4.71

mmol/l

5.34

424

4136

(40768793) Breast Pathology biopsy report

104

0.57

0.62

1.2

1.3

—

(3022145) Colonoscopy Study observation

513

1.19

0.59

1.5

1.4

—

(3025130) Human papilloma virus identified in Specimen

1.47

0.58

2.1

1.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.58

0.0

1.0

—

38.10

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

185

1.31

0.57

2.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

287

1.24

0.53

3.0

3.7

4.70

4.59

pmol/l

0.32

256

(3043238) Trisomy 21 risk [Likelihood] in Fetus

133

0.67

0.52

1.4

1.6

—

(3022621) pH of Urine by Test strip

334

1.21

0.52

2.9

2.1

5.98

6.14

0.62

211

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

1.31

0.49

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

108

0.64

0.49

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

181

1.28

0.49

2.2

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

146

1.31

0.47

1.7

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.42

0.47

6.9

4.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.46

0.47

1.3

1.4

130.94

180.98

pmol/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

468

0.84

0.45

4.1

30.58

31.20

0.17

319

(3047352) Trisomy 18 risk [Likelihood] in Fetus

129

0.69

0.44

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

151

0.72

0.43

1.3

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.62

0.43

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.52

0.41

1.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.41

0.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.40

0.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

725

1.12

0.40

1.8

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.39

0.38

1.0

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.39

0.38

2.2

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.39

0.38

3.4

2.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.29

0.37

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.65

0.36

1.0

1.2

5.14

3.28

ug/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

697

0.89

0.35

1.4

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

296

0.84

0.34

1.8

1.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.34

0.34

1.2

1.1

—

72.20

—

(3050129) First trimester maternal screen panel - Serum or Plasma

188

0.79

0.34

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

175

1664

1.08

0.33

2.1

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.28

0.32

1.7

1.3

—

nmol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

153

0.78

0.31

1.2

1.5

0.91

1.19

ratio

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

153

0.78

0.31

1.3

1.5

0.90

0.97

ratio

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

269

1.16

0.30

1.6

1.3

—

(3008898) HLA-B27 [Presence]

238

0.83

0.29

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.27

0.28

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

243

1.16

0.27

1.2

1.1

—

173.00

—

(3005570) Glucose [Moles/volume] in Urine

1.32

0.23

2.2

3.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

134

1.20

0.23

1.2

2.0

2.26

4.90

iu/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

172

1.17

0.22

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

143

1370

1.06

0.22

4.7

4.4

1.71

1.80

ug/l

0.15

127

1256

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

1.19

0.21

1.2

1.1

—

0.08

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.22

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.89

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

9.8

—

4.72

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

4.29

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

9.7

—

5.95

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.21

0.0

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

261

0.88

0.21

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

436

4318

1.08

0.19

5.6

4.7

1.37

1.43

mmol/l

2.20

419

4105

(4024509) Urine culture

156

1.16

0.19

1.9

1.8

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.19

0.18

1.6

1.3

0.63

0.56

nmol/l

—

(4268621) Lupus anticoagulant assay

1.13

0.17

2.6

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

105

1095

0.95

0.17

4.2

3.7

23.97

21.73

0.57

428

(3045424) Erythrocytes [Presence] in Urine

216

1.12

0.16

1.7

2.4

0.00

0.05

estimate

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

532

0.93

0.15

1.8

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.09

0.14

1.4

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.17

0.13

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

221

0.90

0.13

1.7

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

1.12

0.12

1.5

1.6

—

(3019225) pH of Specimen

330

1.07

0.09

3.1

4.2

7.35

7.34

0.17

238

(1002224) Polysomnography panel

328

0.94

0.08

1.1

—

(40768800) Prostate Pathology biopsy report

1.05

0.08

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

842

1.03

0.05

2.6

2.8

0.65

0.72

ug/l

0.45

449

(3000492) Spirometry study

545

1.03

0.05

1.9

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

359

0.97

0.02

1.3

1.2

193.22

137.32

u/ml

0.31

153

(3002523) Influenza virus A Ag [Presence] in Specimen

126

1.03

0.00

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

126

1.03

0.00

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

0.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.00

0.0

11.0

—

10.79

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

3.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

65.79

—

(4038314) Semen analysis, post vasectomy

0.00

0.0

1.3

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

12.54

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.99

-0.00

1.3

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.86

-0.00

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

137.50

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.91

-0.00

1.1

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

-0.00

0.0

1.3

—

1.18

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

4.4

—

0.40

—

(3019174) dRVVT (LA screen)

0.00

-0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3048879) Bone marrow aspiration report

0.00

-0.00

0.0

2.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.02

-0.00

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

52.40

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

82.44

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.00

-0.00

1.4

—

(44806071) Cardiolipin IgM antibody measurement

0.00

-0.00

0.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

-0.00

0.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

0.04

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

-0.00

0.0

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

6.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.00

-0.00

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HEPATITIS_ACUTE_OTHER_VIRAL – Other acute viral hepatitis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other acute viral hepatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other acute viral hepatitis (HEPATITIS_ACUTE_OTHER_VIRAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints